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II. Abstract. 
 
My PhD project was aimed at applying microfluidics technology to the study of long-
range neurotrophin signalling. Neurotrophins are target-derived growth and survival 
factors that, among other functions, prevent innervating neurons from undergoing 
apoptosis. Neurotrophins and their receptors have been shown to be transported 
retrogradely in axons of spinal cord neurons, following a pathway they share with the 
tetanus neurotoxin binding fragment (TeNT Hc), and which is controlled by the small 
GTPase Rab7. The Rab7-dependent pathway is thought to trigger downstream 
signalling events such as the phosphorylation of the transcription factor CREB, 
important in promoting neuronal survival and differentiation, but direct evidence for 
this had not yet been provided. 
 
To provide direct evidence of this functional relationship between Rab7 activity and 
CREB phosphorylation, I established microfluidic cultures of spinal cord motor and 
sensory neurons, in which axonal networks can be treated independently of cell bodies. 
I used a microfabrication technique known as soft lithography to produce microfluidic 
chambers. They consist of two parallel compartments interconnected by an array of 
microgrooves. In this culture system, dorsal root ganglia (DRG) neurons cultured in one 
of the compartments (somato-dendritic side) can be chemoattracted by gradients of 
nerve growth factor (NGF) to grow their axons preferentially into the other 
compartment (axonal side). 
 
Control studies by immunofluorescence confocal microscopy of CREB phosphorylation 
following direct stimulation of DRG cell bodies with NGF in mass cultures and in 
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microfluidic chambers showed no significant differences between these two systems, 
confirming that the signalling cascade remains unmodified in microfluidic cell cultures. 
Time-course analysis of CREB phosphorylation in DRG neurons prepared from E18.5 
embryos surprisingly revealed a lack of response following NGF stimulation of axon 
terminals in microfluidic cultures. I tried DRG cultures from E14.5 embryos because a 
fraction of the total population of DRG neurons during development undergo apoptosis 
at around E15-E16 if they fail to reach their target tissues. In these cultures, CREB 
phosphorylation could be observed when stimulating axons with NGF in microfluidic 
chambers. These results suggest that this long-range signalling pathway is active during 
a period of development when DRG neurons depend critically on their supply of target-
derived neurotrophins, but it is down-regulated at later developmental stages. 
 
To gain some further insight into the mechanisms controlling this long range signalling 
response, and specifically to study the role of Rab7 in this context, I infected E14.5 
DRG neurons with lentivirus carrying wild type or a dominant negative mutant of Rab7 
(Rab7T22N) coupled to a fluorescent tag. Overexpression of mCherry Rab7T22N affected 
CREB phosphorylation, significantly reducing the signal generated in distal axons. To 
confirm this result, I prepared lentivirus carrying shRNA sequences targeting Rab7, and 
analysed the response to axonal NGF after knocking down the endogenous protein. This 
different approach also abolished CREB phosphorylation after NGF stimulation of the 
axonal network in microfluidic chambers. My results provide a direct link between 
Rab7 activity and downstream effects of the signalling cascade initiated by 
neurotrophins at axonal networks in compartmentalised microfluidic chambers. 
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1.1 Microfluidics as a tool to study long-range neurotrophin signalling. 
 
This project aimed at studying aspects of the neurotrophin signalling cascade, when 
only the axonal networks of primary neurons in culture were exposed to different 
probes. In order to ensure that only axonal networks are exposed to neurotrophins, 
neurons must be cultured in compartmentalised chambers. In these devices, axons can 
be induced to grow into a separate compartment by gradients of neurotrophins. My 
approach consisted in adapting for this purpose a model chamber based on microfluidics 
technology that had been recently described (Taylor et al., 2005). 
 
Compartmentalised microfluidic devices helped me study in detail the signalling 
cascade initiated by neurotrophins. I wanted to study how signals that neurons initiate at 
their axon terminals when the neurotrophins bind their receptors can be propagated to 
the cell bodies. More specifically, I wanted to determine to what degree this cascade 
depends on the axonal retrograde transport of signalling endosomes and on the activity 
of a key regulator of axonal transport, Rab7. 
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1.1.1 Microfluidic devices. 
Microfluidics is a growing technology that uses microfabrication techniques for novel 
applications in problems of biological relevance (Whitesides, 2006). The key feature of 
all microfluidic-based methods is the small size of the devices, where all components of 
the experiment are miniaturised to fit in what is sometimes called lab-on-a-chip (Figure 
1.01A). Because of their small size, these devices use significantly less volumes of 
reagents, which can be of interest in applications in which reduced amounts of samples 
need to be analysed, or when using expensive reagents or reagents available in limited 
amounts, such as antibodies. Microfluidics technologies have found applications in drug 
discovery screens (Dittrich and Manz, 2006), PCR reactions (Krishnan et al., 2002), 
detection systems (deMello, 2006), protein crystallisation screening chips (Hansen and 
Quake, 2003; Li et al., 2006) and cell culture devices (El-Ali et al., 2006). Recently, 
sophisticated chambers for nematode immobilisation in which to perform complicated 
procedures such as laser axotomies have been developed (Ben-Yakar et al., 2009). 
 
Microfluidic cell culture devices can be used for single cell experiments (Le Gac and 
van den Berg, 2010). A general application for these devices is in studies of cell 
migration, observing the response of cell populations to different gradients of 
chemoattractants or repellents applied to separate compartments in microfluidic 
chambers (Irimia et al., 2007). Microfluidic chambers can be specifically designed to 
trap individual cells and subject them to more than one treatment simultaneously, 
placing them under a non-mixing stream with two different reagents (Takayama et al., 
2003). 
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The application relevant to this thesis is the use of this type of microfluidic devices as 
compartmentalised chambers for the culture of primary neurons (Pearce and Williams, 
2007). In compartmentalised chambers, neuronal cell bodies can be cultured 
independently of their axonal networks, which can be induced to grow into a separate 
compartment by gradients of chemoattractants. This system was initially used to study 
neuroregeneration in cortical and hippocampal neurons following axotomy (Taylor et 
al., 2005). Recently these authors have adapted their system to visualise and manipulate 
synapses with the addition of a perfusion channel (Taylor et al., 2010). 
 
These devices can be fabricated using an array of microfabrication techniques 
(micromachining, micromoulding, lithographic methods, etc) depending on the specific 
application. The most popular in biological applications because of its ease of use is 
known as soft lithography. Soft lithography offers the advantage of fast prototyping, in 
that a device can be designed and produced in just a few days (reviewed in McDonald et 
al., 2000). This method involves the production of a tridimensional relief that can be 
used as a mould and copied repeatedly with polydimethylsiloxane (PDMS). PDMS is a 
biocompatible transparent polymer that can be poured onto the mould in liquid form as 
an oligomer and further crosslinked to a rubbery solid state by adding a curing agent 
and applying a thermal treatment. This device can also be cut to an adequate shape and 
attached to a number of cell culture devices. These finished devices are called 
microfluidic chambers. 
 
Microfluidic devices can be used in combination with other microfabrication 
techniques, such as micropatterning. This consists of the application of specific coatings 
on cell culture systems, forming patterns for cells to preferentially adhere to. In a 
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representative application, the orientation of the cell division axis for individual cells 
cultured on geometrically restricted patches of extracellular matrix can be determined 
(Thery et al., 2005). 
 
Such an approach has already been tested in cultures of cortical neurons in microfluidic 
chambers (Figure 1.01B). Patterned lines of polylysine in this system direct the growth 
of axons in a parallel manner into an isolated compartment (Taylor et al., 2003). 
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Figure 1.01: Microfluidic devices. (A) A microfluidic device used to study the growth 
of microbial populations. Microfluidic devices can miniaturise complicated circuitry to 
the size of a coin (Picture taken from Whitesides, 2006). (B) The combination of 
microfluidics with substrate micropatterning can be used to direct the parallel growth of 
axons into an isolated compartment (Picture taken from Taylor et al., 2003). 
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1.2 Neurotrophin signalling. 
 
Neurotrophins are target derived growth and survival factors that among other functions 
prevent neurons innervating target tissues from undergoing apoptosis. The neurotrophin 
family of proteins is formed by nerve growth factor (NGF), brain derived neurotrophic 
factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5). Each 
neurotrophin binds a specific tyrosine kinase receptor (Figure 1.02). These are TrkA 
(Tropomyosin related kinase A) for NGF, TrkB for BDNF and NT-4/5 and TrkC for 
NT-3. However, NT-3 can also bind with less affinity to the receptors TrkA and TrkB. 
All neurotrophins also bind a general receptor p75NTR, which belongs to the TNF 
(tumour necrosis factor) receptor family (Huang and Reichardt, 2001, 2003). 
 
1.2.1 Neurotrophins. 
The most studied member of the neurotrophin family is the Nerve Growth Factor 
(NGF). NGF was discovered in the 1950s by Stanley Cohen, Rita Levi-Moltancini and 
Viktor Hamburger, who found that a protein factor derived from the limbs of embryos 
was essential in ensuring the viability of the neurons innervating those areas. Once they 
could purify the protein, they observed that it promoted sprouting of neurites from 
sympathetic and sensory ganglia explants (Cohen et al., 1954). They also found that it 
could be used to maintain dissociated sensory and sympathetic neurons in culture (Levi-
Montalcini and Angeletti, 1963). NGF was eventually shown to facilitate axon 
navigation and act as a potent chemoattractant for the axons of chick sensory neurons 
(Gundersen and Barrett, 1979). 
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Figure 1.02: Neurotrophin receptors. Each neurotrophin binds to its specific tyrosine 
kinase receptor (left). NGF binds to TrkA, BDNF and NT-4/5 bind to TrkB and NT-3 
binds to TrkC. However NT-3 can also bind TrkA and TrkB with lower affinity. All 
neurotrophins can bind the p75NTR (right). 
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NGF and the other members of the neurotrophin family are synthesised as 
proneurotrophins. These are 30-34 kDa precursors that need to be cleaved in order to 
yield the C-terminal mature forms of neurotrophins of approximately 13 kDa. However, 
it has been seen that they are not always processed in a similar manner. ProBDNF is 
synthesised in the endoplasmic reticulum and trafficked to the Golgi, where the pro 
domain of the protein binds the receptor sortilin and assists in the proper folding of the 
protein. BDNF has also a motif that can be recognised intracellularly by a sorting 
receptor called carboxipeptidase E (CPE), which directs the protein towards the 
regulated secretory pathway (Chen et al., 2005). NGF instead lacks this CPE 
recognition motif and is secreted by constitutive secretion. This differential sorting can 
explain why NGF is secreted as the mature form, while BDNF is mainly secreted as 
proBDNF. Since NGF is not directed to secretory granules, it can be cleaved by the 
protease furin in the trans-Golgi network. BDNF instead is cleaved extracellularly by 
tPA (tissue plasmin activator)-activated plasmin or matrix metalloproteases reviewed in 
(Lu et al., 2005; Teng et al., 2010). 
 
Proneurotrophins are not just the precursors of mature neurotrophins. They also have 
intrinsic biological activity. They can bind a receptor complex formed by sortilin and 
p75NTR at the plasma membrane and initiate an apoptotic signalling response (Nykjaer 
et al., 2004; Teng et al., 2005). Upon pro-domain cleavage, the neurotrophins form 26 
kDa homodimers that bind to p75NTR and specific Trk receptors. 
 
1.2.2 The Trk receptors. 
The Trk receptors were discovered as oncogenic proteins in tumours, fused to 
tropomyosin (Barbacid et al., 1991). They were soon found to be tyrosine kinase 
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receptors (RTKs), with a ligand-binding extracellular portion, one single 
transmembrane domain, and a tyrosine kinase intracellular domain. The extracellular 
portion consists of three N-terminal leucine-rich motifs flanked by two cysteine clusters 
and followed by two IgG-like domains. It is the second IgG-like domain that typically 
acts as the binding site for neurotrophins. Upon ligand binding, these receptors dimerise 
and get activated by auto-phosphorylation at specific tyrosine residues of their 
intracellular domains. 
 
A total of 10 tyrosine residues get phosphorylated upon neurotrophin binding. Three of 
these are located in the activation loop of the kinase domain (Y670, Y674 and Y675 in 
the numeration corresponding to human TrkA). Of the seven tyrosine residues that get 
phosphorylated outside the activation loop, two have been well characterised, Y490 and 
Y785. Mutations in the remaining five have been shown to impair neurite outgrowth in 
PC12 cells, but the mechanistic details on how these phosphorylation sites contribute to 
neuronal differentiation remain poorly understood. These phosphorylated tyrosine 
residues can act as anchoring sites for a number of adaptor proteins or adaptor domains 
of effector proteins. As a result, when these receptors get activated they recruit a 
number of signalling molecules, and can initiate several signalling cascades, such as the 
PLC-γ (phospholipase C), PI3K (phosphoinositide 3-kinase) and the MAPK (mitogen-
activated protein kinase) pathways directly from the plasma membrane.  
 
The PLC-γ pathway can be activated by the direct binding of PLC-γ to the 
phosphorylated Y785 of the TrkA receptor. PLC-γ gets phosphorylated and cleaves its 
substrate PtdIns(4,5)P2 to produce Ins(1,4,5)P3 and diacylglycerol (DAG). Ins(1,4,5)P3 
increases the levels of intracellular Ca2+, which activates Ca2+-dependent PKC and the 
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Ca2+ and calmodulin dependent kinases CaMKII and CaMKIV. There are few studies 
directly analysing this pathway in cultures of primary neurons. However, it has been 
shown that NGF induces both an extracellular Ca2+ influx and intracellular Ca2+ 
mobilization in 3T3 cells expressing NGF receptors (Jiang et al., 1999). 
 
The MAPK pathway is triggered at the plasma membrane by recruitment of the PTB 
(phosphotyrosine binding) domain of Shc (Src homology 2 domain containing) to 
phosphorylated Y490. Shc itself recruits Grb2 (growth factor receptor-bound protein 2) 
and this interacts with Sos (son of sevenless), which is a GEF (guanine nucleotide 
exchange factor) for the small GTPase Ras (rat sarcoma). Sos stimulates Ras to 
exchange its GDP for GTP. Ras-GTP can then activate directly c-Raf (a MAPKKK). 
Ras-GTP can also activate the class I PI3K, present at the plasma membrane. 
 
The PI3K pathway is normally activated by Ras upon activation of Trk receptors, but it 
can also be activated by Ras independent mechanisms. Activated PI3K phosphorylates 
PtdIns(4,5)P2 to generate PtdIns(3,4,5)P3, which can recruit various proteins to the 
plasma membrane, among them PDK1 (phosphoinositide dependent kinase 1) and Akt 
(also known as PKB, protein kinase B). When both proteins are brought to the plasma 
membrane, PDK1 can phosphorylate Akt at its Thr308 position. PI3K can also 
indirectly stimulate the phosphorylation of Ser473 through mTORC2 (mammalian 
target of rapamycin complex 2), which is required for maximum activation of Akt 
(Pearce et al., 2010). Once fully activated, Akt can act on several substrates. Important 
in survival is the phosphorylation of BAD, which in its phosphorylated form can be 
sequestered by 14-3-3 therefore inhibiting BAD’s pro-apoptotic effects. 
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Upon NGF binding, the TrkA receptor is polyubiquitinated and this is required for its 
internalisation (Geetha et al., 2005a). Defects in this polyubiquitination mechanism by 
expression of a K63R mutant ubiquitin or absence of TRAF6 (tumour necrosis factor 
receptor –associated factor 6, an E3 ubiquitin ligase) have been shown to interfere with 
most of the signalling cascades triggered by neurotrophins and abolish NGF-dependent 
neurite outgrowth in PC12 cells, which indicates that receptor endocytosis is an 
essential step in the signal transduction mechanism of neurotrophin activated Trk 
receptors (Geetha et al., 2005a). 
 
Trk endocytosis can occur in a dynamin-1 dependent manner, via caveolin-mediated 
endocytosis or through Pincher-dependent macropinocytosis (Figure 1.03) (Zweifel et 
al., 2005) and there is evidence that NGF can recruit signalling complexes to clathrin-
coated vesicles (Howe et al., 2001). Macropinocytosis has been studied mostly in 
systems where Pincher was overexpressed and it remains to be seen what could be the 
role of this internalisation pathway in physiological conditions (Shao et al., 2002; 
Valdez et al., 2005). Internalised receptors can interact in endosomal membranes with 
subsets of adaptor molecules different from those present at the plasma membrane and 
this seems important in the modulation of the signal. This was first described for the 
prototypical RTK, the epidermal growth factor (EGF) receptor (Di Guglielmo et al., 
1994). 
 
Trk receptors are in fact very similar to the EGF receptor. Strikingly, in PC12 cells EGF 
induces cell proliferation, whereas NGF stimulates cells to differentiate into a neuronal 
phenotype (Marshall, 1995). Differences in activation kinetics of the MAPK signalling 
cascade may explain this effect. EGF produces short-lived ERK activation through 
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Figure 1.03: Trk receptor internalisation. The Trk receptor has been found to use 
three different routes of internalisation into cells: clathrin, caveolin and pincher-
mediated endocytosis (Picture taken from Zweifel et al., 2005). 
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transient activation of the intermediates Ras and Rap1, lasting a maximum of 15 
minutes. NGF instead produces sustained ERK activation. In this case Ras activation is 
transient, but Rap1 activation is maintained for periods of at least an hour (Kao et al., 
2001). 
 
Ras activation is transient in both cases, involving the recruitment to the activated Trk 
receptor of the scaffolding molecules Shc and Grb2, and the GEF for Ras Sos. Sos is 
under the control of a negative feedback loop upon activation of the MAPK pathway. 
ERK proteins phosphorylate pp90RSK2, which in turn phosphorylates Sos, causing its 
deactivation and the downregulation of this pathway (Kao et al., 2001). 
 
Rap1 activation depends on the formation on endosomes of a complex containing a 
member of the Crk family, of which CrkL is normally the most abundant form in 
neurons, and C3G, a Rap1 GEF (Wu et al., 2001). This complex is directly bound to the 
EGF receptor, but it is very rapidly dissociated. In NGF dependent Trk activation, the 
complex is stabilised by the presence of an additional scaffolding protein, FRS2, which 
gets phosphorylated by activated Trk receptors. It is believed that FRS2 stabilisation of 
the complex allows for the sustained activation of both Rap1 and ERK (Kao et al., 
2001). 
 
It is interesting to note that Ras activity occurs at the plasma membrane, whilst Rap1 on 
endosomes (Nomura et al., 2004). Also, Ras activation is believed to activate the 
MAPK pathway through c-Raf. Rap1 activates B-Raf instead. This also contributes to a 
longer lasting effect since B-Raf was found to activate the pathway more efficiently 
(Kao et al., 2001). Supporting this hypothesis, NGF treatments had different effects in 
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PC12 cells overexpressing a temperature sensitive form of dynamin, depending on 
whether or not internalisation was allowed. NGF was found to have a survival effect on 
the cells when endocytosis was blocked, but it stimulated differentiation into a neuronal 
phenotype if endocytosis was allowed (Zhang et al., 2000). 
 
Rap1 however can dissociate from the FRS2-Crk-C3G complex and progress with the 
Trk receptor along the endocytic pathway. In late endosomes, Rap1 can recruit its 
guanine nucleotide exchange factor PDZ-GEF1 and maintain sustained activation. PDZ-
GEF1 forms a heterotetramer complex together with the Trk receptor, 
Kidins220/ARMS (kinase D interacting substrate of 220 kDa/ Ankyrin repeat-rich 
membrane spanning) and the scaffolding protein S-SCAM (synaptic scaffolding 
molecule), in vesicles that are positive for Rab7 (Hisata et al., 2007). Disruption of this 
signalling complex in late endosomes reduces the sustained phosphorylation of the ERK 
pathway and impairs neurotrophin dependent neurite outgrowth in PC12 cells and in 
hippocampal neurons. 
 
In summary, this is a very complex network of interactions, and it might vary depending 
on the expression of the different adaptors in different cells. 
 
1.2.3 The p75NTR receptor. 
In addition, all neurotrophins bind the p75NTR receptor. p75NTR is a single 
transmembrane domain protein. Its extracellular portion consists of four cysteine rich 
(CR) domains. CR2 and CR3 have been mapped as the regions responsible for 
neurotrophin binding. The intracellular portion is called the death domain. p75NTR can 
bind the Trk receptors, increasing their affinity for neurotrophins and potentiating their 
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anti-apoptotic effects, but it can also form complexes with other plasma membrane 
proteins or intracellular domain adaptor proteins and be involved in pro-apoptotic 
signals. It responds to ligands such as MAG (myelin associated glycoprotein), Nogo and 
OMGP when it forms a receptor complex together with NogoR and Lingo-1. This 
receptor complex sequesters the RhoA-GDI (GDP dissociation inhibitor) protein, 
allowing the small GTPase RhoA to exchange GDP for GTP. Activated GTP-bound 
RhoA produces growth cone collapse and inhibits neurite outgrowth (Lu et al., 2005). 
Also as described previously, p75NTR can form a receptor complex with sortilin and 
bind proneurotrophins with high affinity. 
 
Like other members of the TNF receptor family, p75NTR can activate a pathway that 
results in the nuclear translocation of NFκB. This mechanism, reviewed in (Huang and 
Reichardt, 2003), depends on a neurotrophin-dependent recruitment to the intracellular 
domain of p75NTR of the effectors TRAF6 and IRAK (Interleukin 1 receptor-associated 
kinase), which can subsequently recruit the atypical protein kinase C-ι (aPKC-ι) and 
p62. This complex can phosphorylate the IκB kinase β (ΙΚΚβ), which in turn 
phosphorylates IκB. Phosphorylated IκB is subjected to polyubiquitination and targeted 
for proteosomal degradation, thus releasing NFκB. Once freed of the inhibitory IκB, 
NFκB can translocate to the nucleus and activate transcription. 
 
In sympathetic neurons, TRAF6 has also been found to polyubiquitinate NRIF 
(neurotrophin receptor interacting factor) upon p75NTR stimulation. NRIF can then 
translocate to the nucleus where it acts as a transcription factor (Geetha et al., 2005b). 
This pathway requires cleavage of p75NTR and the interaction of the intracellular domain 
(p75-ICD) with TRAF6 and NRIF (Kenchappa et al., 2006). p75NTR can be cleaved in a 
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sequential manner reminiscent of Notch processing (Kanning et al., 2003) (Jung et al., 
2003). First TACE (an α-secretase) cleaves the extracellular portion of the receptor, and 
subsequently a γ-secretase mediates an intramembrane cleavage step that releases the 
intracellular domain. Interestingly, p75-ICD has been coupled to NFκB activation 
(Kanning et al., 2003), and other studies stress the function of the γ-secretase cleavage 
in regulating the interaction between the p75NTR and Trk receptors, by limiting the 
availability of the transmembrane domain necessary for this association (Jung et al., 
2003). Other apoptosis effectors that interact with p75NTR are NRAGE (neurotrophin 
receptor interacting MAGE homolog) and NADE (p75NTR associated cell death 
executor). These two proteins can activate the JNK/p53 pathway and promote apoptosis 
(Frade, 2000). 
 
A recent review proposes a model for the biological role of p75NTR in the response of a 
cell to neurotrophins. According to this model (Blöchl and Blöchl, 2007), p75NTR 
appears to synergise with the trophic effects of Trk receptor signals under normal 
neurotrophin stimulation, but counteracts it by promoting cell death in situations of 
neurotrophin hyperstimulation. Such a model implies that target derived neurotrophins 
are not the only limiting factor contributing to survival of neuronal populations, but that 
these are also under the control of death signals, which would prevent excessive growth 
of neurons that establish an excessive number of innervations. In mature neurons, this 
additional control would not be needed and that seems to correspond to a general 
downregulation in the expression levels of the p75NTR receptor (Blöchl and Blöchl, 
2007). 
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In any case, there is an equilibrium between the cell survival and cell death signals that 
p75NTR can trigger, and these depend on whether or not Trk receptors are present. 
p75NTR is more likely to induce apoptosis in the absence of Trk. Recently, some 
scaffolding proteins have been discovered that bind both Trk and p75NTR, potentially 
influencing how the two interact. One of these proteins, Kidins220/ARMS (Iglesias et 
al., 2000; Kong et al., 2001), is phosphorylated by Trk receptors upon neurotrophin 
activation (Arevalo et al., 2006), and seems to have an active role in integrating the 
signalling pathways that both receptors can elicit. 
 
In the context of the TNF family, p75NTR is unusual in that it forms a dimer instead of a 
trimer. This dimer has been found to exist independently of neurotrophin binding. The 
dimer is linked by a disulphide bond mediated by the cysteine in position 257 of the 
p75NTR (in the vicinity of the transmembrane domain of the receptor). Upon binding the 
neurotrophin, the dimer undergoes a conformational change that is transmitted to the 
intracellular domains, thus initiating the response to neurotrophins (Figure 1.04). 
Mutations in Cys257 completely abolished the response of p75NTR to neurotrophins. 
Interestingly, the response to other ligands such as MAG, mediated by a complex of 
p75NTR with NogoR and Lingo-1, was unaffected by this mutation (Vilar et al., 2009b). 
Confirming the key role for a disulphide bridge in this mechanism, cysteine-scanning 
mutagenesis in the juxtamembrane region confers the receptor constitutively active 
signalling capabilities that mimic the response of p75NTR to neurotrophins, but that are 
different from the p75NTR signalling pathways triggered by other ligands such as MAG 
(Vilar et al., 2009a). These results show that p75NTR has the ability to discriminate 
between different ligands (i.e. between neurotrophins and MAG). 
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Figure 1.04: Activation of p75NTR. Neurotrophin binding causes a conformational 
change in the p75NTR dimer that is transmitted to the intracellular domains and this is 
important in signal transmission. Mutations in Cys257 abolish the response of p75NTR to 
neurotrophins (Picture taken from Vilar et al., 2009b). 
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Regarding its internalisation, it has recently been shown that prior to neurotrophin 
treatment, p75NTR is trafficked in a rapid recycling pathway that depends on dynamin 
but which is clathrin independent. However, NGF treatments on motor neurons redirect 
p75NTR to a clathrin dependent pathway and this is linked to the axonal retrograde 
transport route (Deinhardt et al., 2007). 
 
1.2.4 The signalling endosome theory. 
It is now generally accepted that receptor endocytosis upon ligand binding is not only a 
way of terminating the signal, but rather a mechanism for further modulation of the 
signal. It brings activated receptors in contact with different subsets of adaptor 
molecules on endosomal membranes, which may be essential in signal transduction. 
Therefore the name signalling endosome refers to an endosomal structure carrying 
active signal transduction molecules. In the specific case of neurons, which bind target-
derived neurotrophins from distant sources there is the additional problem of physically 
transporting signalling endosomes over distances that exceed by several orders of 
magnitude those covered by other cell types. A compartmentalised culture system for 
cultures of primary neurons popularly known as Campenot chambers (Campenot, 1977; 
Campenot et al., 2009) has been instrumental in understanding how signals applied to 
axon terminals can be transmitted in a retrograde manner to the neuron cell body in 
order to promote survival and influence gene expression (Wu et al., 2009). 
 
It is believed that ligand binding to the p75NTR and Trk receptors at nerve terminals has 
local signalling effects such as cytoskeleton remodelling, which can lead to growth cone 
stirring and chemotaxis in response to gradients of neurotrophins. However, some of 
these activated receptor carrying endosomes are directed to the axonal retrograde 
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transport route. They eventually reach the cell soma, where they can engage additional 
signalling molecules, which mediate the activation of transcription factors such as 
CREB (c-AMP response element binding protein), SRF (serum response factor) and 
MRTF-A (myocardin-related transcription factor A), also known as MAL 
(megakaryocytic acute leukemia) (Riccio et al., 1997; Wickramasinghe et al., 2008b), 
among other functions. Several groups have established that transport of ligand-receptor 
pairs from axons is absolutely necessary for the phosphorylation of CREB in 
compartmentalised cultures of dorsal root ganglia (DRG) neurons (Watson et al., 1999) 
and to prevent apoptosis in superior cervical ganglia (SCG) neurons supported with 
NGF in the axonal compartment (Ye et al., 2003). 
 
An active PI3K pathway both in the distal axons and in the soma has been found to be 
essential for survival of SCG neurons for a period of at least 72 hours (Kuruvilla et al., 
2000). Also an active MAPK pathway has been found to be necessary for the 
phosphorylation of CREB in compartmentalised cultures of DRG neurons (Watson et 
al., 2001). This group found that local application of neurotrophins resulted in an 
activated MAPK pathway mediated by both Erk1/2 and Erk5. Strikingly, only Erk5 was 
activated in cell bodies upon neurotrophin treatments of distal axons. 
 
It is also interesting to note that the different neurotrophins may not necessarily initiate 
the same retrograde signalling cascades and therefore might have different signalling 
outcomes. Both NGF and NT-3 can bind the TrkA receptor and they can support 
survival when added to mass cultures of SCG neurons. However, only NGF, but not 
NT-3, can prevent these neurons from undergoing apoptosis when added to the distal 
axons. It was found that NGF-bound TrkA was internalised but NT-3-TrkA remained at 
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the plasma membrane in SCG neurons overexpressing TrkA for ease of observation. 
TrkC transfected neurons did internalise ligand-receptor pairs upon NT-3 binding 
(Kuruvilla et al., 2004). 
 
The signalling endosome model has been challenged by the surprising finding that NGF 
coupled to beads and unable of internalisation, supported a compartmentalised culture 
of perinatal rat SCG neurons, when added to distal axons for at least 30 hours (MacInnis 
and Campenot, 2002). The same group also found that an active phosphorylated Trk 
receptor was not strictly necessary for survival of compartmentalised SCG neurons for 
48 hours with axonal NGF while maintaining the cell bodies exposed to the Trk 
inhibitors K252a or Gö6976 (MacInnis et al., 2003; Mok and Campenot, 2007). This 
seems to contradict the results found in a different study using perinatal rat SCG 
neurons in Campenot chambers with the same K252a inhibitor, where it was found that 
a phosphorylated Trk is essential for survival for 72 hours (Ye et al., 2003). Whether the 
time point difference or any other factors contribute to this discrepancy has not yet been 
determined. 
 
An alternative model, which does not require axonal transport for the transmission of 
this signal has been proposed based on a similar mechanism observed for EGF when it 
binds the receptor ErbB1. In this case, stimulation with bead-bound EGF, which bound 
a limited number of receptors, triggered a wave of receptor activation in MCF7 cells (a 
breast cancer cell line) that resulted in rapid phosphorylation of all receptors at the 
plasma membrane (Verveer et al., 2000). This wave model could explain how 
phosphorylated Trk receptors have been found in somal compartments of Campenot 
chambers 1 minute after adding NGF to axonal compartments, when 125I-NGF could be 
Chapter 1. Introduction
 
 
Page 41 
detected after 1 hour (Senger and Campenot, 1997), a result difficult to explain with the 
signalling endosome hypothesis. However, this has never been tested in neurons. Other 
models suggest that second messengers downstream of Trk phosphorylation might be 
retrogradely transported independently of ligand-bound receptors. As an example, axons 
and growth cones of developing neurons have been found to contain CREB mRNA, 
which is translated in response to external stimuli (Cox et al., 2008). This axonal CREB 
was found to be essential for CREB-mediated transcription and NGF-dependent 
survival in cultures of rat E15 DRG neurons. In any case it is very possible that these 
additional signalling modes complement ligand-receptor endosomes, and they may play 
different roles depending on the physiological context (Figure 1.05). 
 
An additional contentious point is the actual nature of the signalling endosome as an 
organelle. Some groups have found evidence for early endosomal markers in retrograde 
carriers in the sciatic nerve (Delcroix et al., 2003), whereas others show that retrograde 
transport depends on the activity of late endosomal markers (Deinhardt et al., 2006b). 
 
1.2.5 The transcription factor CREB. 
Regardless of the signal transmission pathway, it is widely accepted that one of the 
main downstream effects of neurotrophin signalling is the activation of the transcription 
factor CREB by phosphorylation at its Ser133, reviewed in (Lonze and Ginty, 2002; 
Mayr and Montminy, 2001). CREB (cAMP response element binding protein) belongs 
to the bZIP superfamily of transcription factors and it forms the CREB subfamily 
together with the related gene products CREM (cAMP response element modulator) and 
ATF-1 (activating transcription factor 1). CREB’s structure comprises a N-terminal 
glutamine-rich domain Q1, followed by a KID domain (kinase inducible domain), and a 
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Figure 1.05: The signalling endosome. Activated neurotrophin receptors are 
internalised upon ligand binding at axon terminals and transported towards cell bodies 
in a dynein dependent manner. These endosomal structures are believed to carry 
activated signalling molecules, which may in turn activate transcription factors in the 
nucleus (Picture taken from Cosker et al., 2008). 
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second glutamine-rich domain Q2 (also called the CAD or constitutively active 
domain). Finally, there is a basic region leucine-zipper bZIP domain (dimerisation and 
DNA binding region) at the C-terminal region of the protein. CREB binds to itself and 
to CREM or ATF-1 to form homo or heterodimers. These dimers bind to the CRE 
promoter, which consists of the palindromic sequence 5’-TGACGTCA-3’. However, 
they have been found to also bind the truncated sequence 5’-CGTCA-3’. There are 4710 
CRE palindromes in the human genome (Mayr and Montminy, 2001) and the many 
different genes under the control of CREB, which can be assigned to various categories 
such as signal transduction, transcription, cellular metabolism, structural elements, 
growth factors and neurotransmitters. CREB regulates its own expression. Also the 
expression of the CREB transcription repressor ICER (inducible cAMP response 
element repressor) is CRE driven (Mayr and Montminy, 2001). NGF and BDNF have 
been found to promote cell survival by CREB-driven expression of Bcl-2, an anti-
apoptotic protein (Riccio et al., 1999). 
 
CREB gets activated by a large number of external stimuli, such as electrical activity, 
stress, and growth and survival factors to name a few. It can be activated by cAMP, 
which binds to the regulatory subunits of PKA, releasing the catalytic subunits of the 
kinase, which translocates to the nucleus and phosphorylates CREB. However, 
cAMP/PKA is not the only pathway triggering this effect. CaMKIV has been shown to 
directly phosphorylate CREB in the presence of elevated levels of intracellular Ca2+ 
(Spencer et al., 2008). CREB has been found to be a target of Akt (Du and Montminy, 
1998). And also the kinases MSK1 and RSK2 can phosphorylate CREB in the presence 
of an active MAPK cascade. 
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The phosphorylation of CREB at Ser133 is necessary but not always sufficient for 
CREB dependent gene transcription. Phosphorylation of Ser133 does not have an effect 
on DNA binding of the leucine zipper, but it rather mediates the interaction between the 
CREB KID domain and the KIX domain of CBP (CREB binding protein). Some genes 
under the control of a CRE promoter require that phosphorylated CREB binds its 
interacting protein CBP, but this is not always necessary. Stimuli that activate CREB 
through PKA or CaMKIV do not need the interaction with CBP, but this interaction is 
essential for the transcription of genes when CREB has been activated by mitogenic or 
stress signals. 
 
CREB has been implicated in post-synaptic plasticity. Activation of CREB can trigger 
the expression of proteins that can modify synapse strength (Harris, 2008). It is believed 
that these gene products can only be retained by active synapses, therefore 
strengthening these and not those without inputs (Benito and Barco, 2010). CREB can 
initiate a first wave of gene expression (immediate early genes), some of which 
products are transcription factors. These in turn can initiate a second wave of gene 
expression. Some immediate early genes such as c-fos are under the control of CRE and 
SRE (serum response element). This indicates that CREB must cooperate with other 
transcription factors such as SRF (serum response factor) in the expression of certain 
genes. Interestingly, the same neurotrophin induced MAPK pathway that results in the 
phosphorylation of CREB can activate SRF (Knöll and Nordheim, 2009), which can 
partially explain how the same transcription factor produces very different outcomes in 
response to a wide variety of stimulus. 
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CREB null mutations are perinatally lethal, which allows the study of embryonic 
development in the absence of CREB. Knockout mice embryos have increased 
apoptosis in sensory neurons and they fail to establish appropriate innervations 
throughout the body because of defects in axonal growth (Lonze et al., 2002). However, 
excess apoptosis in the central nervous system (CNS) was not observed. It is believed 
that CNS neurons fail to show a severe phenotype because the family members CREM 
and ATF-1 are likely to have a compensation effect. Indeed CREM upregulation has 
been observed in brains of CREB knockout mice (Rudolph et al., 1998). 
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1.3 Membrane trafficking. 
 
It is becoming increasingly clear that signals originated from receptor tyrosine kinases 
are not restricted to the plasma membrane with endocytosis being merely a mechanism 
of signal attenuation. Instead, internalisation of ligand receptor pairs into endosomal 
structures is now consider to modulate signalling cascades, by promoting the 
recruitment of subsets of adaptors and effectors different from those present 
immediately underneath the plasma membrane (Hisata et al., 2007). Endocytosis of Trk 
receptors has been found to be important in promoting differentiation in PC12 cells 
responding to NGF, while signalling from the plasma membrane in PC12 cells 
expressing a defective form of dynamin promotes growth (Zhang et al., 2000). 
 
These results highlight the dependence of neurotrophin signalling on intracellular 
membrane trafficking pathways. Intracellular membrane traffic ensures the homeostasis 
of membrane compartments within the cell. It includes the sorting of membrane 
components and their cargo along the secretory and endocytic routes and to the different 
cellular organelles. Cells use the secretory pathway to transport outwards newly 
synthesised materials towards the plasma membrane or other organelles. The endocytic 
pathway is used instead to internalise nutrients from outside the cell or to degrade waste 
products in lysosomes. 
 
Such important processes need to be tightly regulated and the cell uses several strategies 
to control membrane trafficking. Phosphoinositide remodelling is a key mechanism in 
this regard. Phosphoinositides are phospholipids with an inositol head group that can be 
phosphorylated in three different positions, and these modifications are performed by a 
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large group of specialised kinases and phosphatases (Rusten and Stenmark, 2006). 
Small GTPases are also an important family of proteins with functions in controlling 
membrane trafficking events. Rabs (Ras in brain) are one of the most important proteins 
in this group. Rabs, together with phosphoinositides have been found to form one type 
of coincidence detection motifs essential for the recruitment of various proteins to 
specific membranes. Coincidence detection requires the presence of a recognition factor 
in addition to a specific phosphoinositide for the recruitment of proteins to their targeted 
intracellular localisations. These additional factors can be small GTPase proteins such 
as the Rabs, but also other lipids, motif-containing receptors or membrane curvature 
(Carlton and Cullen, 2005; Di Paolo and De Camilli, 2006). Finally, there is an 
emerging family of proteins, the sorting nexins (SNXs), which are being described as 
having important functions in regulating sorting events within the cell. 
 
1.3.1 Phosphoinositides. 
Phosphoinositides make up only a small fraction of the entire lipid composition of 
cellular membranes, but are very important in many cellular processes such as cell 
signalling and membrane trafficking. Many kinases and phosphatases are involved in 
transforming different phosphoinositides by adding or removing phosphate groups from 
specific sites on the inositol ring (Figure 1.06). 
 
Different phosphoinositides decorate different cellular membranes (Figure 1.07) (De 
Matteis and Godi, 2004; Kutateladze, 2010). For example, phosphatidylinositol (4,5)-
bisphosphate (PtdIns(4,5)P2) is enriched in the plasma membrane, where it can be 
phosphorylated in the 3-position by the Class I PI3K to form PtdIns(3,4,5)P3. This 
phosphorylation reaction can be reverted by the PTEN phosphatase, which can function 
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Figure 1.06: Phosphoinositide metabolic enzymes. Kinases are presented in blue and 
phosphatases in purple. DAG: diacylglycerol, PTEN: phosphatase and tensin homolog, 
OCRL: oculocerebrorenal syndrome of Lowe, MTM1: myotubularin 1, MTMR: 
myotubularin related PI phosphatase, SHIP: SH2 domain-containing inositol 5-
phosphatase, PIKfyve: FYVE domain-containing PI kinase (Picture taken from Rusten 
and Stenmark, 2006). 
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Figure 1.07: Distribution of phosphoinositide species in cellular membranes. PI4P 
(phosphatidylinositol 4-phosphate) is enriched in the trans Golgi network, PI(4,5)P2 in 
the plasma membrane, PI(3,4,5)P3 in active zones of the plasma membrane, PI(3,4)P2 in 
internalised vesicles, PI3P in early endosomes (EE) and PI(3,5)P3 in the outer 
membrane of multivesicular bodies (MVB) (Picture taken from Kutateladze, 2010). 
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as a tumour suppressor negatively regulating Akt signalling. PtdIns(3,4)P2 is also 
present at the plasma membrane in low quantities and it is an important signalling 
intermediate, which is generated in response to external stimuli as the product of 
dephosphorylation of PtdIns(3,4,5)P3 at the 5-position by type II 5-phosphatases, such 
as INPP5B (Schmid et al., 2004). But PtdIns(3,4)P2 can also be synthesised by an 
indirect route, after dephosphorylation of PtdIns(4,5)P2 by OCRL (Erdmann et al., 
2007) and subsequent phosphorylation of the resulting PtdIns(4)P by the class I PI3K. 
 
Early endosomes are enriched in PtdIns(3)P, and the endosomal population of this 
phosphoinositide is believed to be maintained by the endosomal specific Class III PI3K, 
also called Vps34. In endosomes, PIKfyve (mammalian orthologue of Fab1 in yeast), a 
FYVE domain containing kinase, binds PtdIns(3)P and uses it as a substrate to produce 
PtdIns(3,5)P2, the predominant phosphoinositide species in the outer membrane of 
multivesicular bodies (MVBs). However, internal vesicles of MVBs are enriched in 
PtdIns(3)P. PtdIns(4)P can be found in the Golgi apparatus and it is a substrate for the 
synthesis of PtdIns(4,5)P2. Finally, PtdIns(5)P is not very abundant, but it is believed to 
occur naturally in cells because it is the preferred substrate of type II PIP-kinases to 
produce PtdIns(4,5)P2 (Rameh et al., 1997). 
 
Phosphoinositides are very important in trafficking and signalling events due to their 
ability to mediate the recruitment of soluble adaptor proteins to their specific organelles. 
These proteins typically have a phosphoinositide-binding domain that recognises the 
lipid moiety. Examples of these domains are the PH (pleckstrin homology), PX (phox 
homology) and FYVE (found in Fab1, YOTB, Vac 1, and EEA1) domains, but other 
phosphoinositide binding domains have been described (Kutateladze, 2010; Rusten and 
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Stenmark, 2006). PH domains have been well studied and different PH domains have 
different binding affinity towards phosphoinositides, with some recognising certain 
forms very specifically, such as PtdIns(4,5)P2 and PtdIns(3,4,5)P3. For example, the PH 
domain of PLCδ binds PtdIns(4,5)P2 (Dowler et al., 2000), while the PH domain of Akt 
binds to PtdIns(3,4)P2 and PtdIns(3,4,5)P3 (Watton and Downward, 1999) and the PH 
domain of phosphatidylinositol 4-phosphate adaptor protein 1 (FAPP1) binds to 
PtdIns(4)P (Dowler et al., 2000). PX domains instead bind preferentially to PtdIns(3)P, 
even if some PX domains have been described to also bind other phosphoinositides. 
FYVE domains bind exclusively to PtdIns(3)P. 
 
These phosphoinositide binding domains are responsible for recruiting signalling and 
trafficking effectors to their specific intracellular locations, and therefore 
phosphoinositide production and turnover must be tightly regulated. Misregulation of 
many of the kinases and phosphatases responsible for phosphoinositide transformation 
have been linked to a number of diseases, including cancer and neurodegenerative 
disorders (Bunney and Katan, 2010; Chow et al., 2007; Erdmann et al., 2007). 
 
1.3.2 Rab GTPases. 
Rabs are a family of small monomeric GTPases (approximately 60 in humans) that 
regulate many membrane trafficking steps (Figure 1.08). These proteins belong to the 
Ras superfamily of small GTPases and they act as molecular switches that cycle from 
an “on-state” in which they are bound to GTP, to an “off-state” when they are bound to 
GDP. This exchange between GTP and GDP is an important feature of Rab GTPases 
because the guanine nucleotide bound influences the array of effector proteins that are 
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Figure 1.08: Distribution of Rab GTPases in cellular membranes. Rab GTPases 
localise to specific membranes where they recruit essential effectors for the normal 
functions of the organelle (Picture taken from Stenmark, 2009). 
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recruited. There are several comprehensive reviews on the role of Rab GTPases on 
membrane traffic (Schwartz et al., 2007; Stenmark, 2009; Zerial and McBride, 2001). 
 
Shortly after their synthesis, Rab proteins bound to GDP are recognised by a Rab escort 
protein (REP), which presents the Rab to a geranylgeranyl transferase (GGT), which 
adds a hydrophobic geranylgeranyl group to a cysteine residue at the Rab C-terminus. 
At this point, the protein can be recognised by a GDP dissociation inhibitor (GDI) 
protein. It is this GDI that targets the Rab to the appropriate membrane by interacting 
with a GDI displacement factor (GDF) present in the target membrane. On membranes, 
Rabs are then subjected to the effect of a GEF protein (guanine nucleotide Exchange 
Factor) that releases the bound GDP and incorporates a molecule of GTP. This activates 
the Rab, which can then remain associated to membranes by its geranylgeranyl group. 
Rab-GTP can interact and recruit various specific effectors to the intracellular 
membranes it decorates (Stenmark, 2009). Eventually, GTP-bound Rab proteins 
become the substrate of GTPase activating proteins (GAPs), which stimulates their 
intrinsic GTPase activity, thereby transforming GTP in GDP. This transformation 
releases effectors that only bind to the Rab-GTP form. Eventually Rab-GDP itself can 
be released from the membrane and bind a GDI, which again stabilises the GDP-bound 
form and prepares the protein for further rounds of the Rab cycle (Figure 1.09). 
 
Specific point mutations can alter the ability of Rab proteins to bind guanine 
nucleotides (Papini et al., 1997). A mutation of Ser/The for Asn in the guanine 
nucleotide-binding pocket can increase the preference for GDP over GTP, whereas a 
substitution of a Asn for Ile results in low affinity for either GTP or GDP. These 
mutations are both considered dominant negative. On the contrary, a mutation of Gln 
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Figure 1.09: The Rab cycle. A newly synthesised GDP-bound Rab protein can be 
recognised by the REP (Rab escort protein), which presents it to the GGT 
(geranylgeranyl transferase). Geranylgeranylated Rab-GDP can then associate to GDI 
(GDP dissociation inhibitor), which is removed by the GDF (GDI displacement factor) 
at the specific membrane. GEF proteins (guanine nucleotide exchange factor) can 
exchange the Rab’s GDP for GTP and this GTP-bound Rab can insert its 
geranylgeranyl group in the membrane and bind its effectors. GAP proteins (GTPase 
activating protein) can stimulate the Rab’s intrinsic GTPase activity and the GDP-bound 
Rab can dissociate from the membrane. It is then recognised by a GDI and the cycle can 
start again (Picture taken from Stenmark, 2009). 
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for Leu in the active site of the protein affects is GTPase activity and results in a 
constitutive active GTP-bound mutant. 
 
1.3.3 Rab5. 
Rab5 is one of the best-characterised members of the Rab family. It is typically 
considered an early endosomal marker, but has also been found to associate to other 
membranes, such as macropinosomes or phagosomes. Rab5 has been described as a 
regulator of phosphoinositide turnover in the early stages of the endocytic pathway. It 
can be recruited to the plasma membrane where it interacts with the activated type I 
PI3K (p85α- p110β-PI3Kβ) (Christoforidis et al., 1999b). Rab5 associated to GTP has 
been shown to interact with a PtdIns(3,4,5)P3 5-phosphatase and a PtdIns(3,4)P2 4-
phosphatase. This interaction was not found for Rab5-GDP (Shin et al., 2005) and it is 
believed to regulate the uncoating of clathrin-coated vesicles. Finally, Rab5 interacts in 
early endosomes with the type III PI3K (Vps34-p150) (Nielsen et al., 1999). 
 
The reason for this localised interaction with Vps34 in early endosomes can be found in 
the feedback loops that result in the formation of Rab5 domains within these endocytic 
structures (Zerial and McBride, 2001). Rab5 can interact with the adaptor protein 
Rabaptin5 on these membranes and Rabaptin5 recruits Rabex5, a Rab5 GEF, to form a 
complex. This complex stabilises a localised population of GTP-bound Rab5 and 
stimulates the recruitment of other Rab5 effectors, among them Vps34. Vps34 can 
phosphorylate phosphatidylinositol at its 3-position generating PtdIns(3)P, which is the 
main phosphoinositide found in early endosomes. This has an immediate effect as it 
allows the recruitment of other Rab5 effectors which have double recognition motifs for 
both Rab5 and PtdIns(3)P, such as the early endosomal marker EEA1 and Rabenosyn5. 
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These proteins work as tethering factors facilitating docking of membranes and 
collaborating with SNARE proteins in facilitating homotypic fusion events of early 
endosomal membranes (Christoforidis et al., 1999a). 
 
1.3.4 Rab7. 
Rab5-positive early endosomes have been found to mature into late endosomes in a 
process that involves the exchange of Rab5 for Rab7 in a gradual step called Rab 
conversion (Rink et al., 2005). This sequential replacement of Rab5 for Rab7 has been 
shown to be necessary for the correct spatio-temporal sequence of event in essential 
cellular processes such as axonal transport (Deinhardt et al., 2006b), phagosome 
maturation (Vieira et al., 2003) and in the recruitment of important sorting molecules 
such as the retromer complex (Rojas et al., 2008; Seaman et al., 2009). 
 
Recently, a switch mechanism controlling Rab conversion between Rab5 and Rab7 has 
been elucidated. Two groups working separately on a nematode model have found that 
mature Rab5 positive endosomes eventually create signals (endosome size as a result of 
homotypic fusion or elevated contents of PtdIns3P) that recruit SAND-1 (Mon1 is the 
mammalian orthologue) to these endosomal membranes (Kinchen and Ravichandran, 
2010; Poteryaev et al., 2010). SAND-1/Mon1 displaces Rabex5 from Rab5 domains, 
therefore interfering with the positive feedback loop that keeps Rab5 in its GTP-bound 
active state (Poteryaev et al., 2010). At the same time, SAND-1/Mon1 forms a complex 
with Ccz1 and this complex has the ability of binding Rab7, displacing the GDI 
inhibitor that keeps Rab7 in its inactive GDP-bound state (Kinchen and Ravichandran, 
2010). This renders the protein susceptible to the action of the HOPS complex, which 
has Rab7 GEF activity (Poteryaev et al., 2010). However, one must keep in mind that 
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the nature of specific Rab7 GEF and GAP proteins are still a matter of debate. A recent 
report confirmed TBC1D15 to be a Rab7 GAP, but their Rab7 GEF candidate (Vps39) 
failed to modify Rab7-GTP levels (Peralta et al., 2010). 
 
Even if Rab7 functions have not been fully characterised, it is considered a general 
marker for late endocytic structures within the cell. One of its best-understood functions 
is its involvement in the fusion of late endosomes to lysosomes, a process that needs the 
interaction between Rab7-GTP and RILP (Rab-interacting lysosomal protein) 
(Cantalupo et al., 2001). RILP has been shown to be a required factor in the regulation 
of the morphology and function of late endosomes (Progida et al., 2007). Additionally, 
Rab7-GTP and RILP can form a complex with ORP1L (oxysterol-binding protein-
related protein 1L). When forming part of this complex, RILP can interact with 
p150Glued, a component of the dynein-dynactin motor complex (Figure 1.10), and 
stimulate minus end-directed motor activity along microtubules (Johansson et al., 
2007). 
 
1.3.5 Sorting nexins. 
The sorting nexins (SNX) are a phosphoinositide-binding family of proteins possessing 
a characteristic PX domain (Cullen, 2008). Many of them also have a BAR domain 
(bin-amphiphysin-rvs), which can sense or induce membrane curvature (Frost et al., 
2008). These proteins have been found to play important roles in sorting events 
throughout the cell and they bind to specific membrane locations. 
 
The retromer is a large protein complex, which controls the recycling of specific cargo 
such as sortilin and the mannose 6-phosphate receptor from early endosomes to the 
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Figure 1.10: The Rab7-RILP-ORP1L complex. Once assembled on the late 
endosomal (LE) membrane, this complex can recruit the molecular motor dynein-
dynactin complex, which propels the organelle towards the minus-end of microtubules 
(Picture taken from Johansson et al., 2007). 
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trans Golgi network (TGN) (Mari et al., 2008). It is composed of a membrane binding 
element and a cargo recognition subcomplex (Bonifacino and Hurley, 2008). The 
membrane binding element is a dimer of sorting nexins, which can be any two of these 
four: SNX1, SNX2, SNX5 and SNX6 (Wassmer et al., 2009). These proteins use a 
coincidence detection mechanism to bind to endosomal membranes: their PX domain 
binds preferentially to PtdIns(3)P, while their BAR domain binds to curved membranes. 
A recent report has shown that SNX5 and SNX6, but not SNX1 or SNX2, can bind 
directly to the p150glued subunit of the dynactin-dynein complex, providing a direct link 
between the retromer complex and molecular motors (Wassmer et al., 2009). The cargo 
recognition subcomplex is a trimer composed of Vps29, Vps35 and Vps26 (Hierro et 
al., 2007). Interestingly, the sequential action of Rab5 and Rab7 has been found to be 
required for the recruitment of the retromer complex to endosomal membranes (Rojas et 
al., 2008). 
 
SNX3 has been recently reported to colocalise with FYVE domain-containing 
endosomal protein Hrs (hepatocyte growth factor-regulated tyrosine kinase substrate), a 
component of the ESCRT-0 (endosomal sorting complex required for transport) 
complex, which directs monoubiquitinated cargo towards the internal vesicles of 
multivesicular bodies (MVBs) (Pons et al., 2008). Surprisingly, this group found Hrs to 
be dispensable in vesicle biogenesis but essential for lysosomal targeting, whereas 
SNX3 was required for vesicle formation, but not for targeting to lysosomes. 
 
The transferrin receptor (TfnR) is known to recycle back to the plasma membrane after 
endocytosis in a Rab11-dependent manner. Interestingly, SNX4 has been shown to 
regulate recycling of TfnR through the Rab11-positive endocytic recycling 
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compartment (ERC) by associating to its effector KIBRA (Kidney and brain protein), 
which forms a complex with the dynein light chain 1 (Traer et al., 2007). 
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2.1 Microfluidic chambers for compartmentalised cultures of primary neurons. 
 
In order to study long range neurotrophin signalling, a cell culture system is required in 
which cell bodies and axons can be stimulated and analysed separately. The field of 
long range neurotrophin signalling has traditionally used the system developed by 
Robert Campenot (Campenot, 1977), a compartmentalised neuron culture device widely 
known as Campenot chambers (Riccio et al., 1997; Watson et al., 2001). 
 
However, experiments performed with Campenot chambers are labour intensive and 
they have the additional problem of an intrinsic variability, since the chamber assembly 
steps depend on the skills of the operator. Also, these chambers require plastic bottom 
Petri dishes, greatly restricting their use in fluorescent high-resolution approaches. 
Furthermore, compartmentalisation is achieved by using an opaque Teflon divider, 
which makes the system difficult to use with microscopy techniques (Campenot et al., 
2009). 
 
Microfluidic chambers offer a good alternative in that they are always copied against a 
mould (called a master), and therefore the geometry of all chambers is always the same, 
independent of the operator (Park et al., 2006). Also, they are made of a transparent 
material, polydimethylsiloxane (PDMS), which facilitates the use of this system in 
combination with most glass-bottom Petri dishes compatible with high-resolution 
microscopy methods. 
 
A standard design of microfluidic chambers consist of four reservoirs or wells, each two 
connected by two large parallel channels, which were 20 mm long, 1 mm wide and 150 
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µm high. These channels are the compartments or sides of the microfluidic device and 
they are interconnected by an array of microgrooves. The microgrooves are the key 
feature, which confers the isolation properties of these devices. They act as a barrier to 
cell crossing between the different compartments, while allowing growth of axons 
across them. I designed the microgrooves to be 800 µm long, 10 µm wide and 3-4 µm 
high. These dimensions were required for the microgrooves to isolate successfully both 
compartments. Initial designs, in which microgrooves were 500 µm long, could not 
prevent a fraction of glial cells from invading the axonal side. Occasionally neurons 
could also be found in the axonal side. This was never observed in chambers with 800 
µm long microgrooves. 
 
2.1.1 Fabrication of microfluidic chambers. 
I developed my microfluidic devices using a soft lithography approach (Figure 2.01). 
Soft lithography is a rapid microfabrication technique, which allows the user to design, 
fabricate and test a prototype device in just a few days. This method involved a first step 
of lithography to produce a tridimensional relief, followed by a replica moulding step to 
repeatedly copy these features in pieces made of PDMS (McDonald et al., 2000). 
Briefly, in the lithography part of this process, a silicon wafer was covered with a thin 
film of a UV light photosensitive compound, SU-8, and this was irradiated with UV 
light through a pattern printed in a photomask. Only irradiated SU-8 crosslinked on the 
silicon wafer and formed the relief. The excess SU-8 was removed with a 
propyleneglycol methyletheracetate wash. This method was successful in producing a 
mould referred to as the master (Figure 2.02 A), which could be used to produce 
microfluidic devices by replica moulding. In this final step of the procedure, liquid 
PDMS was mixed with a curing agent and polymerised inside the master. PDMS 
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Figure 2.01: Fabrication of microfluidic chambers by Soft Lithography. A 
tridimensional master is produced by patterning a silicon wafer surface with a SU-8 
photoresist in an initial Photolithography step (top panel). This master is used in a 
subsequent Replica Moulding step (bottom panel) to copy many microfluidic devices in 
a highly reproducible manner using polydimethylsiloxane (PDMS). 
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became a solid silicone rubber that could be easily peeled from the master and cut to the 
desired shape to adapt to glass or plastic surfaces. This replica moulding step could be 
repeated several times with one single master. 
 
However, repetitive use of these masters for microfluidic chamber fabrication resulted 
in de-lamination of the patterned SU-8 photoresist and breakage of the Silicon wafer 
after 10-20 uses. I solved this problem by producing an alternative secondary master in 
epoxy resin (Figure 2.02 B). Production of these secondary masters involved the use of 
the very first PDMS piece from the original silicon/SU-8 master as a mould to be 
replicated with the epoxy resin mix. The resulting epoxy masters were very robust and 
not prone to failure with frequent use. PDMS pieces produced with epoxy masters were 
observed under the scanning electron microscope (SEM) and their features showed the 
exact same dimensions as pieces produced with the original moulds (length 800 µm, 
width 10 µm, height 3-4 µm). SEM studies of these PDMS pieces were carried out in 
collaboration with Anne Weston in the Electron Microscopy Unit (Figure 2.03). 
 
PDMS pieces need to be mounted on a glass or plastic surface to obtain finished cell 
culture devices. The decision as to what type of surface to use when assembling the 
chambers highly depends on the experimental work to be carried out with the system. I 
typically used high quality 50 mm- diameter glass-bottomed dishes for live cell imaging 
and immunofluorescence applications. Regular microscope slides where preferred for 
western blot experiments, as the glass-bottomed dishes can be fairly expensive. Finally, 
PDMS flat surfaces were found to be optimal for electron microscopy studies 
(Discussed in 2.3.3, this thesis). 
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Figure 2.02: Masters for microfluidic chamber fabrication. SU-8/ silicon masters 
(A) were brittle and prone to failure after a reduced number of uses. Epoxy resin 
masters (B) could be used repeatedly without breaking. Scale bars: 20 mm. 
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Figure 2.03: Schematic representation and SEM images of microfluidic chambers. 
Scanning electron micrographs of PDMS pieces copied from original SU-8/Silicon 
wafer masters are shown on the right. A bottom view is shown in the top right and a 
cross section is shown in the bottom right with detail (insert). Microfluidic chambers 
consist of four wells, connected in pairs by two lateral channels or compartments 
(20mm long, 1mm wide and 150µm high). These are called the somal side and the 
axonal side, and they are in turn connected by an array of microgrooves. These 
microgrooves are 800µm long, 10 µm wide and 3-4 µm high. Scale bars: 100 µm. SEM 
of PDMS device by Anne Weston. 
 
Chapter 2. Results
 
 
Page 68 
PDMS pieces can be attached to glass or plastic reversibly or irreversibly (Park et al., 
2006). The reversible bonding attachment forms when the PDMS part is brought into 
contact with a suitable surface (i.e. glass). Irreversible bonding on the other hand can 
only be produced after treating both surfaces with a plasma cleaner, which temporarily 
modifies the surface chemistry of both glass and PDMS. This creates reactive chemical 
groups that can form irreversible chemical bonds if brought into contact immediately 
after plasma treatment. The reversible method has the problem of producing a relatively 
high percentage of leaky chambers (40-50%), especially if the two surfaces are not 
perfectly clean when brought into contact. This may happen when work cannot be 
carried out in a clean room or sterile environment. On the other hand the irreversible 
method presents the disadvantage of making the cells inaccessible to direct 
manipulation once they are confined inside the device. However the irreversible seal 
between the PDMS device and the substrate is always watertight and does not leak. 
 
2.1.2 Fluidic isolation in microfluidic chambers. 
The entire concept is based on the principle of communicating vessels, which 
establishes that containers joined at their base and filled with a homogenous, ideal 
liquid will reach the same level in equilibrium regardless of their shape and volume. 
Because in microfluidic chambers the shape and volume of all wells is the same, one 
can achieve equilibrium considering loaded volumes instead of the height of liquid in 
the peripheral wells. 
 
I next tested the fluidic isolation of the separate compartments using a visible marker 
(Figure 2.04) and a radioactive tracer, [32P]-γ-ATP. In the radioactive isolation 
experiment, chambers were kept at 37°C for different times with the following volume 
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Figure 2.04: Isolation of compartments in microfluidic chambers. 200 µl of buffer 
were loaded on the left compartment (somal side) whereas 160 µl of bromophenol blue 
containing buffer were loaded on the right compartment (axonal side). This difference 
in volume creates fluid flow in the direction of the bromophenol blue labelled-
compartment through the microgrooves (See Figure 2.03). This flow prevents any 
diffusion of the dye into the somal side, effectively isolating the compartment and 
confining the probe in the axonal side of the device. The photo shown was taken 24 
hours after loading the chamber. 
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differences: 100 µl per well in the somal side (a total of 200 µl between the two wells), 
and 80 µl per well in the axonal side (a total of 160 µl). At the initial time point t = 0 
hours, all radioactive signal was found in the axonal side and none from the somal side 
(background signal is only 0.1% of the total). At t = 24 hours fluid isolation was still 
maintained and radioactive signal came only from the axonal side. Only after 48 hours, 
2% of the total radioactive signal could be detected from the soma compartment in the 
isolation experiment (Figure 2.05). When loading was reversed in a control experiment 
and the radioactive marker was added in the axonal side with a higher volume, a small 
signal (0.5% of total radioactivity) was already detected in the somal side after 3 hours 
and it was clearly visible after 24 hours (5% of total radioactive signal). This control 
indicates that these volume differences force a steady flow from the compartment with a 
higher volume towards the compartment with a lower volume. The fact that after 48 
hours only 11.4% of the radioactive signal came from the somal side under forced flow 
shows that long time points are required before the system finds an equilibrium. 
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Figure 2.05: Assessment of fluidic isolation in microfluidic chambers. In a 
preliminary isolation experiment (black squares), 200 µl of cold solution were loaded in 
the somal side against 160 µl of [32P]-γ-ATP radioactive solution in the axonal side. 
Radioactivity could not be detected in the somal compartment 24 hours after the 
beginning of the isolation experiment, confirming fluidic isolation was maintained up to 
this time point (red arrow). In a control experiment, loading volumes were reversed; 160 
µl of cold solution were loaded against 200 µl of radioactive solution (black circles). 
This control indicates that these volume differences force a steady flow from the 
compartment with a higher volume towards the compartment with a lower volume. 
Radioactive counts are presented as percentage of counts in the somal side compared to 
total radioactive counts in the somal and axonal sides combined. Additional time points 
will be needed to determine more precisely when fluidic isolation is lost. This 
experiment should be repeated with microfluidic chambers in which neuronal cultures 
have established axonal networks in order to assess how the reduction of the channel 
size because of the axons might affect flow through the microgrooves. 
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2.2 Microfluidic cultures of primary neurons. 
 
2.2.1 Spinal cord motor neurons. 
Once I had optimised my initial design of microfluidic chambers, I tested their 
suitability for compartmentalised cultures of spinal cord motor neurons. Two important 
parameters that needed to be optimised were the biocompatibility of the device as well 
as the ability of the neuronal cultures to establish dense axonal networks into the axonal 
side, which could allow for biochemical experiments to be performed with this system. 
 
Motor neurons were loaded into poly-ornithine/laminin coated chambers immediately 
after primary cell preparation and kept in the device for five to ten days before use, to 
let the cells establish a mature axonal network. However, the network that developed in 
the axonal side was never as dense as that in the somal compartment. I could confirm 
that these few neurites, which grew into the axonal side, were indeed axons as they were 
positive for the axonal marker SMI 31 and negative for the dendritic marker MAP2 
(Figure 2.06). 
 
I tried to improve the rate of crossing into the axonal side by adding gradients of BDNF 
and HGF, which have been described to act as chemoattractants for spinal cord motor 
neurons (Jacob et al., 2001). However, consistent results could not be obtained, and in 
most experiments the rate of crossing (number of neurons per chamber that can extend 
an axon into the axonal side) in cultures chemoattracted with BDNF, HGF or both was 
similar to control cultures. 
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Figure 2.06: Microfluidic cultures of primary motor neurons. E14.5 rat spinal cord 
motor neurons (DIV12) extend axons (labelled with SMI 31 in red), but not dendrites 
(labelled with MAP2 in blue) into the axonal compartment in the absence of a 
chemoattractant. Neurons were cultured in complete motor neuron medium (See Section 
4.1.5). Scale bar: 250 µm. 
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In these initial motor neuron cultures, only 5-20 neurons would cross the microgrooves, 
out of approximately 1000 neurons grown in the somal side of the chamber. 
Occasionally, some of the chambers had no axons crossing. Markers such as lipophilic 
carbocyanine dyes (DiI and related compounds) or cholera toxin subunit B (CTB) were 
used to trace retrogradely the cell bodies of motor neurons that extended their axons 
into the separate axonal compartment (Figure 2.07). 
 
Whilst still useful for live-cell imaging transport experiments, the very low proportion 
of neurons extending axons across the microgrooves made it extremely difficult to use 
the cultures for any other applications (i.e. cell signalling by immunofluorescence, 
electron microscopy, western blot). 
 
2.2.2 Dorsal root ganglia (DRG) sensory neurons. 
In an attempt to solve the problem linked to the low numbers of axons crossing the 
microgrooves, I next tested cultures of alternative neuronal types, which were known to 
respond well to chemoattractants. The goal here was to obtain cultures that would 
establish dense axonal networks into the axonal side of chambers, so that they could be 
used with a wider range of analytical techniques. 
 
P0 SCG sympathetic neurons and E18.5 DRG sensory neurons were initially tested and 
successfully chemoattracted by gradients of NGF. Axons started appearing in the axonal 
side on the second or third day after plating, and by the fifth day in vitro, almost all of 
the neurons had already extended an axon into the axonal side of the chamber (Figure 
2.08). 
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Figure 2.07: Retrograde labelling of motor neurons in microfluidic chambers. 
E14.5 rat motor neuron axonal networks were exposed to 50 ng/ml of Cholera Toxin 
Subunit B (CTB), labelled with Alexa555, in the axonal side of microfluidic chambers, 
in the absence of a chemoattractant. The probe was internalised after 2 hours incubation 
and transported to the motor neuron cell body, where it accumulated. This procedure 
labelled motor neurons, which extend axons into the axonal side of microfluidic 
chambers. Neurons were cultured in complete motor neuron medium, as previously 
described (See Figure 2.06). Fluorescence and differential interference contrast (DIC) 
images shown. Scale bar: 250 µm. 
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Figure 2.08: Retrograde labelling of DRG neurons in microfluidic chambers. E18.5 
DRG (DIV5) axons were chemoattracted towards the axonal side of a microfluidic 
chamber with a gradient of 200 ng/mL of NGF. The axonal network was exposed to 
40nM TeNT Hc Alexa488 and 50 ng/mL CTB Alexa555, and then incubated for 5 
hours to allow for internalisation and retrograde transport of the probes. DRG neurons 
were imaged live in an inverted microscope. 
 
Chapter 2. Results
 
 
Page 77 
After applying an optimised chemoattraction protocol (see Materials and methods), 
cultures older than DIV3 were kept with NGF in the axonal side only. This favoured the 
development of very dense axonal networks (Figure 2.09). 
 
The denser axonal networks and the fact that almost all neurons extended axons into the 
axonal compartment made it possible for these chambers to be used for biochemical 
assays, electron microscopy and other techniques that require most cells in the culture to 
be exposed to the specific treatments. 
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Figure 2.09: Optimised DRG cultures in microfluidic chambers. E14.5 DRG (DIV 
14) axons were chemoattracted towards the axonal side of a microfluidic chamber with 
a gradient of 200 ng/ml of NGF. DRG neurons were fixed inside microfluidic chambers 
with 4% PFA and stained with the mouse monoclonal β-tubulin antibody Tuj1 (See 
Section 4.2.20). The antibody does not penetrate the microgrooves, which are 
completely filled by axons and therefore these portions of axon do not get labelled. 
Scale bar: 200 µm. 
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2.3 Axonal transport. 
 
2.3.1 Axonal retrograde transport of Tetanus toxin. 
Because the aim of this project was to analyse how neurotrophin signalling depends on 
Rab7-mediated axonal retrograde transport, it was essential to have good probes to 
monitor this transport route. An ideal probe for this analysis is the binding fragment of 
Tetanus Neurotoxin (TeNT Hc) (Lalli and Schiavo, 2002), which I have extensively 
characterised in axonal transport experiments in microfluidic chambers. 
 
Upon Clostridium tetani infection, the bacteria release tetanus neurotoxin (TeNT) in the 
host organism. This toxin can be internalised by spinal cord motor neurons via clathrin 
dependent endocytosis at the neuromuscular junction and then follow the axonal 
retrograde transport pathway to the cell bodies of motor neurons, which are located in 
the spinal cord. Once it reaches the spinal cord, TeNT undergoes transcytosis to the 
plasma membrane of the somato-dendritic compartment where it is released and taken 
up by inhibitory interneurons. It is in these inhibitory interneurons that the toxin exerts 
its catalytic effect (Lalli et al., 2003). 
 
Axonal transport experiments in microfluidic chambers offer the advantage of spatially 
controlling the compartment onto which the probe is added. TeNT Hc can be added to 
the axonal compartment of microfluidic chambers, where the probe is internalised and 
sorted into axonal carriers for retrograde transport towards cell bodies. Imaging this 
process within microgrooves offers the advantage of avoiding any interfering signal 
from the plasma membrane, since lateral diffusion of non-internalised probe along the 
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membrane takes longer than vesicular traffic. This lowers significantly the background 
signal. 
 
Results from these experiments can be represented as a movie. Alternative modes of 
presenting the data would be a time series of consecutive frames from the movie or a 
kymograph (Figure 2.10). Kymographs are stacks of a region of interest (ROI) in each 
frame (region corresponding to the axon) for the entire movie. In a kymograph, moving 
carriers leave slanting lines, whereas immobile structures can be seen as vertical traces. 
These transport movies can be subjected to quantitative multi-parametrical analysis. 
More specifically, tracking software is used to obtain dynamic information by analysing 
individual movements of these endocytic carriers to eventually obtain speed distribution 
graphs. 
 
I tracked in excess of one thousand individual movements corresponding to 160 TeNT 
Hc positive carriers from four independent transport movies when the probe was added 
to axon terminals in microfluidic chambers and produced the corresponding speed 
profile, in which individual speed values are plotted against the relative frequency at 
which they appear. I then compared this curve with standard speed distribution graphs 
produced by Dr Lynsey Bilsland at the Molecular NeuroPathobiology laboratory. The 
speed profile for transport carriers in microfluidic cultures of motor neurons fits more 
closely the pattern observed for TeNT Hc transport in the living animal (imaging is 
done on the exposed sciatic nerve after distal injection of the fluorescent probe), rather 
than that found for motor neurons in mass culture (Figure 2.11). This might be due to 
the fact that in microfluidic chambers the architecture of the cultures mimics more 
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Figure 2.10: Axonal retrograde transport of TeNT Hc. 40nM TeNT Hc labelled with 
Alexa555 was added to the axonal side of microfluidic chambers and a transport movie 
was acquired in a section of axon confined inside a microgroove. Transport experiments 
can be represented as time series of frames from a transport movie (A), or as a 
kymograph (B). A kymograph is built by delimiting a region of interest (ROI) in each of 
the frames of the movie, corresponding to the axon. These ROIs get stacked 
sequentially to form a graphical representation of the movie, in which the x-axis 
corresponds to the distance-length of the axon, whereas the y-axis corresponds to the 
time-length of the movie. In a kymograph transport carriers can be seen as slanting 
traces (red stars), whereas immobile structures leave vertical traces (green circles). 
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Figure 2.11: Speed distribution of TeNT Hc axonal retrograde transport in 
different experimental contexts. 40nM TeNT Hc labelled with Alexa488 or Alexa555 
was added to mass cultures (in vitro, blue line), to the axonal side of microfluidic 
chambers (in MFC, green line), or injected in the living animal (in vivo, red line), and 
movies of TeNT Hc transport were acquired (See Section 4.2.13 for details). 160 
transport carriers from 4 different movies were tracked with Metamorph (this represents 
a number of individual movements in excess of 1000). 
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closely the spatial distribution of somato-dendritic and axonal compartments found in 
vivo. 
 
2.3.2 Cholera toxin subunit B shares retrograde transport carriers with TeNT Hc. 
An additional probe to study the axonal retrograde transport pathway is the subunit B of 
cholera toxin (CTB). CTB binds the ganglioside GM1 at the plasma membrane and is 
then internalised via a clathrin independent mechanism. This probe has been used as a 
neuro-anatomical tracer for the retrograde labelling of neurons (Dederen et al., 1994). It 
has also been used to investigate the mechanisms of internalisation of TeNT Hc, as the 
two use different endocytic mechanisms (TeNT Hc enters neurons via a clathrin 
dependent pathway (Deinhardt et al., 2006a)). Surprisingly, I found that in spite of 
different mechanisms of uptake, these two probes share common carriers in the axonal 
retrograde transport pathway (Figure 2.12). 
 
Interestingly, I also observed that when these common transport carriers arrived to the 
cell bodies of spinal cord motor neurons, they underwent differential sorting and the 
probes were directed to different intracellular destinations (Figure 2.13). This 
observation could be exploited to study the sorting machineries involved in directing 
cargo and receptors to their target organelles after retrograde transport. CTB 
accumulates in structures that partially colocalise with the TGN (Figure 2.14) (Feng et 
al., 2004), whereas TeNT undergoes transcytosis in spinal cord motor neurons to reach 
inhibitory interneurons (Lalli et al., 2003). 
 
I tried to characterise further the nature of the target organelles for CTB and TeNT Hc 
after retrograde transport by immunofluorescence with various intracellular markers. 
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Figure 2.12: TeNT Hc and CTB share transport carriers in the axonal retrograde 
transport pathway. AlexaFluor488 TeNT Hc (40 nM) and Alexa555 CTB (1 µg/ml) 
were added to the axonal network of a microfluidic culture of E14.5 rat spinal cord 
motor neurons. Transport movies were obtained from the microgrooves area of the 
chambers. Both probes colocalised in almost 100 % of moving carriers (white 
arrowheads). This experiment was repeated 3 times with 1 µg/ml Alexa555 CTB, once 
with 50 ng/ml Alexa555 CTB and once with 5 ng/ml Alexa555 CTB. Results were 
highly reproducible. Scale bar is 10 µm. 
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Figure 2.13: TeNT Hc and CTB are sorted to different intracellular organelles 
after axonal retrograde transport. Axonal networks of E14.5 rat spinal cord motor 
neurons in microfluidic chambers were exposed to AlexaFluor488 TeNT Hc (40 nM) 
and Alexa555 CTB (1 µg/ml). The probes arrive at the cell bodies of neurons after 
axonal retrograde transport. TeNT Hc retains an endosomal distribution, whereas CTB 
accumulates in internal membranes. Scale bar is 10 µm. 
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Figure 2.14: CTB accumulates in the Trans Golgi Network. Cultures of E14.5 rat 
spinal cord motor neurons (DIV9) in MatTek dishes were incubated with 1 µg/ml 
Alexa555 CTB for 2 hours, and then fixed with 4 % PFA. Fixed samples were 
permeabilised and stained with an anti-TGN46 antibody. Colocalisation between CTB 
and the TGN46 antibody indicates that the toxin accumulates in the Trans Golgi 
Network. Scale bar: 10 µm. 
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Surprisingly, a small proportion of double positive structures colocalised with EEA1, a 
marker for early endosomes, in the somato-dendritic compartment after axonal 
retrograde transport (Figure 2.15). 
 
This was an unexpected result, as retrograde transport carriers are considered to be 
mainly positive for markers in later stages of the endocytic pathway. How these probes 
reach early endosomal structures after axonal retrograde transport remains to be 
determined. One hypothesis would involve the use by these toxins of a transcytotic 
transport route that would direct them to the plasma membrane of the cell body, from 
where they can be re-endocytosed and delivered to early endosomes. 
 
2.3.3 High-resolution studies of the intracellular distribution of TeNT Hc. 
Electron microscopy offers a way of investigating how these probes were sorted 
differently. This technique was used to investigate which organelles could be involved 
in the intracellular pathways used by TeNT Hc. To this end, I adapted the microfluidic 
chamber setup so that electron microscopy experiments could be performed in this 
compartmentalised system after adding appropriate probes selectively to the axon 
terminal. These experiments were carried out in collaboration with Anne Weston in the 
Electron Microscopy Unit, who examined fixed samples after I had carried out the 
transport experiments. 
 
In these experiments, microfluidic chambers were sealed onto thin PDMS slabs in the 
plasma cleaner for irreversible binding and the sealed chamber was mounted on 
microscope slides for ease of use. These devices were treated with the usual coatings 
and primary neurons were loaded in the somal side. After establishing axonal networks, 
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Figure 2.15: TeNT Hc and CTB reach EEA1 positive structures after axonal 
retrograde transport. Axonal networks of E14.5 rat spinal cord motor neurons 
(DIV12) in microfluidic chambers were incubated with 40 nM TeNT Hc and 50 ng/mL 
CTB for 2 hours. Life cell imaging experiments allowed us to identify the axon (white 
arrowhead). Neurons were then fixed with 4 % PFA and stained with a mouse anti-
EEA1 antibody, a marker of early endosomes. Scale bar: 10 µm. 
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cultures were used for experiments in which TeNT Hc coupled to gold nanoparticles 
was added to neurons cultured inside these modified microfluidic chambers. When the 
experiments were completed, cells were fixed and a liquid mix of an epoxy resin was 
run through both channels of the chamber. The epoxy resin was polymerised inside the 
system, thus trapping the neurons. Glass-bottomed Petri dishes could not be used in this 
type of experiments because the glass always cracked the resin every time I tried to 
open the chamber therefore ruining the sample. Instead, mounting the microfluidic 
chamber on a PDMS slab allowed me to cure epoxy resin inside the mounted chamber 
and peel the chamber open afterwards for further sample processing. The thin strips of 
neurons-containing resin were re-imbedded in a bigger block of epoxy resin for ease of 
operation. Using this approach, samples could be recovered after spinal cord motor 
neurons were directly exposed to gold-coupled TeNT Hc in microfluidic chambers. This 
probe was enriched in the plasma membrane in areas of cell-to-cell contact, and it could 
also be found in coated pits, coated vesicles and endosomes (Figure 2.16). I also found 
that multi vesicular bodies (MVBs) were particularly enriched in TeNT Hc. The toxin 
accumulated preferentially in the external delimitating membrane of this organelle. 
Other organelles such as the endoplasmic reticulum (ER) or the Golgi apparatus appear 
devoid of toxin. 
 
I next tried to repeat this experiment adding the probe to axon terminals only. It was not 
possible to complete the experiment using spinal cord motor neurons because of the 
difficulty in finding motor neurons that extended their axons across the microgrooves 
into the axonal side of the chamber and that had therefore been exposed to the probe. 
For this reason, I performed the same experiment with DRG neurons instead. In DRG 
Chapter 2. Results
 
 
Page 90 
 
 
Figure 2.16: Electron microscopy images of TeNT Hc gold internalised by spinal 
cord motor neurons. Cell bodies of E14.5 rat spinal cord motor neurons (DIV9) 
cultured inside microfluidic chambers in the absence of a chemoattractant were directly 
exposed to 40 nM TeNT Hc coupled to 10 nm gold particles. Sample was incubated for 
an hour, then fixed and processed for observation in a Transmission Electron 
Microscope (TEM). TeNT Hc-gold could be observed in areas of cell-to-cell contact 
(A), coated vesicles (B) and endo-tubular structures (C), but it was mainly found to 
accumulate in the outer membrane of MVBs (1 and 2). TEM of fixed samples by Anne 
Weston. Scale bars: 200 nm. 
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microfluidic cultures almost all of the cells project axons into the axonal side. Using 
this alternative system it was possible to look at what intracellular organelles were 
functioning as receiving structures for axonal carriers transporting the probe from the 
axon terminal. In E18.5 DRG neurons, TeNT Hc-gold could be detected in MVBs and 
lysosomes (Figure 2.17). 
 
These results indicate that the probes are distributed differently in spinal cord motor 
neurons and DRG sensory neurons, suggesting that TeNT Hc might use different 
intracellular trafficking pathways in different neuronal types. 
 
2.3.4 Transcytosis of p75NTR. 
In addition to characterising the axonal retrograde transport of widely used tracers such 
as TeNT Hc and CTB, I also studied the axonal retrograde transport of the neurotrophin 
receptor p75NTR. It has been shown that TeNT Hc is transported together with 
neurotrophins and neurotrophin receptors in common endocytic carriers along the 
axonal retrograde transport route (Deinhardt et al., 2006b; Lalli and Schiavo, 2002). 
Since TeNT is known to undergo transcytosis in spinal cord motor neurons after axonal 
retrograde transport to reach inhibitory interneurons, I asked if neurotrophins and 
neurotrophin receptors (in particular p75NTR) could also follow the transcytotic route 
and reach the plasma membrane at the somato-dendritic compartment after axonal 
retrograde transport. 
 
I analysed this hypothesis using a fluorescently conjugated rabbit anti-p75NTR antibody, 
which recognises the extracellular domain of the receptor. I exposed the axonal network 
of P0 superior cervical ganglia (SCG) neurons in microfluidic chambers at 4°C for 15 
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Figure 2.17: Electron microscopy images of TeNT Hc gold internalised by DRG 
sensory neurons.. Axonal networks of E18.5 DRG neurons (DIV7) in microfluidic 
chambers were exposed to 40nM TeNT Hc coupled to 10 nm gold particles and 
incubated for 4 hours at 37ºC and 7.5% CO2. Cells were fixed and processed for 
observation under a Transmission Electron Microscope. The probe could be found in 
MVBs (white arrows) and lysosomes (black arrows). Gold aggregates in lysosomes 
only form when the protein is degraded. Axons were chemoattracted with a gradient of 
200 ng/ml NGF (See Section 4.2.7 for details). TEM of fixed samples by Anne Weston. 
Scale bar: 200 nm. 
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minutes to allow binding to p75NTR, then removed the unbound antibody and incubated 
at 37°C for up to 4 hours to allow for the receptor-antibody complex to be internalised 
and transported to the cell bodies. At different time points, the somal compartment was 
exposed to an AlexaFluor488 labelled anti-rabbit secondary antibody for 15 minutes 
prior to live imaging. This probe was only expected to bind its target if the primary anti-
p75NTR antibody got exposed to the extra-cellular medium at the plasma membrane of 
the somato-dendritic compartment after retrograde transport. 
 
At early time points the signal corresponding to the primary antibody was still very 
weak and the secondary antibody could not be detected. This was probably because not 
enough of the p75NTR antibody had yet been transported to the cell bodies. At later time 
points, a fraction of the p75NTR antibody reached the plasma membrane of the somato-
dendritic compartment, where it could be recognised by the secondary anti-rabbit 
(Figure 2.18). This result provided proof of principle that a fraction of internalised 
neurotrophin receptors could indeed be following a transcytotic route after axonal 
retrograde transport. 
 
These experiments could also be reproduced in E14.5 DRG neurons. In this system, I 
could demonstrate that the colocalisation between the rabbit p75NTR antibody targeting 
the extracellular portion of the receptor and the anti-rabbit secondary antibody was 
specific, since exposing the axon terminals to a rabbit antibody directed against the 
intracellular domain of p75NTR failed to elicit any signal at somal level of microfluidic 
chambers (Figure 2.19). These experiments clearly showed that this effect was highly 
specific. However, the degree of colocalisation between primary and secondary 
antibodies was not always straightforward to observe, because the high concentration of  
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Figure 2.18: Transcytosis of p75NTR in SCG neurons. In a pilot experiment, rabbit α-
p75NTR antibody targeting the extracellular domain of the receptor (red) was bound on 
ice for 15 minutes to the axonal networks of P0 SCG neuronal cultures (DIV8) in 
microfluidic chambers and incubated at 37˚C for the indicated times. Secondary 
antibody (green) was added for 15 minutes in the somal side prior to live cell imaging. 
Colocalised structures corresponding to transcytotic events were only observed at time 
points longer than three hours. Details in highlighted boxes are shown enlarged in insert 
for time point 5h10m. Scale bar: 5 µm. 
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Figure 2.19: Transcytosis of p75NTR in DRG sensory neurons. In a controlled 
experiment, two different rabbit α-p75NTR antibodies were bound on ice for 15 minutes 
to the axonal networks of E14.5 DRG sensory neurons (DIV6) in microfluidic chambers 
and then incubated at 37˚C for 4 hours. One of the antibodies targets the extracellular 
portion of the p75NTR receptor, the other recognises the intracellular domain. Secondary 
antibody was added for 15 minutes in the somal side and cells were imaged live. 
Colocalised structures indicative of transcytotic events can only be observed when the 
antibody recognising the extracellular domain of the p75NTR was used. 3D projections 
of fluorescent images and a single confocal slice for DIC images are shown. Scale bars: 
5 µm. 
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accumulated p75NTR antibody inside the cell masked the dimmer structures present at 
the plasma membrane, which colocalised with the secondary antibody. 
 
I therefore sought to optimise the exposure times to both the primary antibody in the 
axonal networks, as well as to the secondary in the somal side of microfluidic chambers. 
I found that after exposing the axon terminals to α-p75NTR for only 30 minutes and 
adding the secondary antibody for 4 hours, a high degree of colocalisation could be 
observed between the two (Figure 2.20). I found that this colocalisation occurred 
preferentially in the plasma membrane region at the bottom of the cell, where the cell is 
in contact with the substrate (in this case, poly-L-lysine/laminin coated glass). 
 
Triple positive structures could be observed when these cells were fixed with 4% PFA 
and stained with an antibody that recognises EEA1 (early endosomal antigen 1). This 
indicates that these receptors are internalised after transcytosis and they are delivered to 
EEA1-positive early endosomes (Figure 2.21). 
 
It will be interesting to determine if this trafficking route of the neurotrophin receptor 
p75NTR is related to other downstream effects of neurotrophin signalling from axon 
terminals in primary neurons, such as the phosphorylation of CREB. 
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Figure 2.20: Transcytosis of p75NTR in DRG sensory neurons. E14.5 rat DRG 
sensory neurons (DIV6) in microfluidic chambers were incubated in the axonal side 
with a rabbit α-p75NTR antibody targeting the extracellular portion of the receptor for 30 
minutes. Secondary antibody was added for 4 hours in the somal side and cells were 
imaged live. Single confocal slices for all images are shown, corresponding to the plane 
of contact between the cell and the substrate at the bottom of the neuron. Scale bar: 5 
µm. 
Chapter 2. Results
 
 
Page 98 
 
 
Figure 2.21: p75NTR endocytosis following transcytosis. E14.5 rat DRG neurons 
(already shown in Figure 2.20) were fixed with 4% PFA and stained with an anti-EEA1 
antibody that labels early endosomes. Triple positive structures could be observed 
(white arrows), suggesting that the receptor is endocytosed after being exposed in the 
plasma membrane. Individual confocal slices are shown corresponding to the 
perinuclear region. Scale bar: 5 µm. 
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2.4 Neurotrophin signalling. 
 
Upon neurotrophin binding, the Trk receptors dimerise and become phosphorylated in 
several tyrosine positions, which can then recruit signalling intermediates that activate 
various intracellular signalling pathways. One of the main downstream effects of the 
signalling cascade triggered by neurotrophins is the phosphorylation of the transcription 
factor CREB in its serine in position 133 (Lonze and Ginty, 2002). This 
phosphorylation event has been studied in great detail and it has been used as a read-out 
in several studies. Some of these studies have looked at the downstream effects of the 
signalling cascade initiated by neurotrophins when axonal terminals were exposed to 
neurotrophins in compartmentalised Campenot chambers (Riccio et al., 1999; Riccio et 
al., 1997). 
 
2.4.1 Phosphorylation of CREB. 
I optimised a method based on image analysis of immunofluorescence confocal images 
to compare how neurons were stained with an antibody, which recognised specifically 
the phosphorylated form of CREB, after the neurons had been subjected to different 
treatments with neurotrophins. They were also labelled with either a retrograde axonal 
marker such as CTB, or with an antibody that recognised a specific epitope inside the 
nuclei of neurons (NeuN). 
 
I then used the software package Methamorph (Molecular Devices) to calculate the 
average intensity for pCREB staining in a Region of Interest (ROI) determined by the 
nuclear marker NeuN. All images were acquired as 8-bit RGB files, which could be 
separated into the three different colour channels. The relative intensity value for the 
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pCREB staining corresponding to each individual cell (always the green channel in 
these experiments) was always contained within a range that went from 0 to 255 (Figure 
2.22). These values can be plotted in a Tukey’s box-and-whisker plot (For details, 
please see Materials and methods). 
 
I started using this read-out for my experiments with spinal cord motor neurons, but 
results were very inconsistent and no clear activation could be confirmed upon BDNF 
treatment. However, time course optimisation of CREB phosphorylation in mass 
cultures of E18.5 DRG sensory neurons showed a peak of activation after 20 minutes of 
exposure to NGF followed by fast dephosphorylation. I obtained the same result when I 
repeated this experiment in microfluidic chambers and exposed both sides (somato-
dendritic and axonal) to the neurotrophin treatment (Figure 2.23). Next, I performed a 
similar optimisation experiment in which I exposed only the axonal networks of E18.5 
DRG sensory neurons to NGF. In these experiments, no peak of activation could be 
detected in any of the time points tested despite the fact that CREB phosphorylation was 
seen in a positive control in which cells bodies were treated directly with NGF (Figure 
2.24). 
 
This failure in establishing the adequate conditions to follow CREB phosphorylation 
after peripheral stimulation with NGF forced me to replicate previous experiments 
performed in Campenot chambers (Riccio et al., 1997). I adopted their same P0 
Superior Cervical Ganglia (SCG) cell system for these experiments. These cells were 
cultured in microfluidic chambers and they responded very effectively to 
chemoattraction treatments with gradients of NGF as they do when they are cultured 
inside Campenot chambers. However, these cells also failed to phosphorylate CREB 
Chapter 2. Results
 
 
Page 101 
 
 
 
 
 
 
Figure 2.22: Read-out for immufluorescence based signalling experiments. E14.5 
DRG neurons (DIV5) cultured in MatTek dishes were starved of NGF overnight and 
then exposed to medium with or without NGF for 10 minutes at 37ºC in a 7.5% CO2 
incubator. After treatment, neurons were fixed with 4 % PFA and stained with specific 
primary antibodies against phosphorylated CREB (pCREB, shown in green) and a 
specific neuronal nuclear antigen (NeuN, shown in red). pCREB is also presented in 
false-colour in the left panel, indicating how the NGF treatment stimulates the 
phosphorylation of CREB in the position Ser133. Neurons were cultured in DRG 
complete medium, as previously described. Scale bars: 10 µm. 
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Figure 2.23: Time course of CREB phosphorylation upon direct stimulation of cell 
bodies with NGF. E18.5 DRG neurons (DIV8) cultured as indicated were starved of 
NGF overnight (red boxes), and then subjected to NGF treatments (200 ng/mL) for 10, 
20 and 30 minutes (green boxes). Neurons were cultured in either mass cultures 
(MatTek dishes) (A) or in microfluidic chambers (B) and after each treatment, neurons 
were fixed with 4 % PFA, stained with antibodies and images were quantified with 
Methamorph. N=1 for each experiment. The number of cells per condition is indicated 
in brackets under each column. * p<0.05, *** p<0.001. Neurons were cultured in DRG 
complete medium, as previously described. 
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Figure 2.24: Time course of CREB phosphorylation upon axonal stimulation with 
NGF. E18.5 DRG neurons (DIV8) cultured in microfluidic chambers were starved of 
NGF overnight (negative control, red boxes) and then treated with 200 ng/ml NGF as 
described: NGF was added to the axonal networks (blue boxes), or added directly to cell 
bodies (positive control, green boxes). Two separate time courses covering short (A) 
and long (B) time points were performed. N=2 for each time course. Representative 
results are shown. Cells per condition are shown in brackets under each column. n.s. not 
significant, * p<0.05, ** p<0.01, *** p<0.001. Only the positive control is significantly 
different from the negative control with a threshold of p<0.001. Neurons were cultured 
in DRG complete medium, as previously described. 
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when I used the time range previously described for axonal stimulation with NGF. 
Control cells promptly responded to the stimulus when NGF was added directly to the 
somal compartment (Figure 2.25). 
 
At around embryonic day 15-16, DRG sensory neurons have established their 
connections with the tissues they innervate. Those that fail to reach their targets do not 
have access to target supplied neurotrophins, which prevent neurons from undergoing 
apoptosis. I reasoned that only DRG cells at an embryonic stage earlier than this critical 
period of neurotrophin dependence should be responsive to NGF treatments applied 
from the axonal terminals. I therefore repeated the experiment using E14.5 DRG 
neurons. 
 
Direct NGF stimulation of E14.5 DRG cell bodies resulted in a peak in CREB 
phosphorylation 10 minutes after the beginning of neurotrophin treatment. This was a 
significant difference from the response in E18.5 cells where the peak of CREB 
phosphorylation was found after 20 minutes. Additionally, a time course experiment in 
which only axon terminals were exposed to NGF revealed a peak in CREB 
phosphorylation two hours after stimulation (Figure 2.26). This response was not as 
intense as the direct stimulation but it was maintained for a longer period of time. 
 
In order to try to understand if differences in receptor expression could be accounted for 
the different signalling response, I analysed by western blot the expression of NGF 
receptors in the somato-dendritic and axonal sides of microfluidic chambers, both in 
E14.5 and E18.5 DRG cultures. Expression of the neurotrophin receptor p75NTR did not 
show noticeable differences in this assay, but the expression of the Trk receptor 
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Figure 2.25: Time course of CREB phosphorylation in P0 SCG neurons upon 
treatments with NGF. P0 SCG neurons (DIV12) cultured in microfluidic chambers 
were starved of NGF overnight (negative control, red box) and then treated with 200 
ng/ml NGF as described: NGF was added to the axonal networks (blue boxes), or added 
directly to cell bodies (positive control, green boxes). N=1. Cells per condition are 
shown in brackets under each column. n.s. not significant, * p<0.05, *** p<0.001. 
Axonal stimulation with NGF for 60 mins results in levels of CREB phosphorylation 
significantly different from the negative control. However, this is not due to an increase 
of the phosphorylation levels, as expected after NGF treatment. This result might be 
corrected increasing N for this pilot experiment. Neurons were cultured in DRG 
complete medium, as previously described. 
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Figure 2.26: Time course of CREB phosphorylation in E14.5 DRG neurons upon 
treatments with NGF. E14.5 DRG neurons (DIV8) cultured in microfluidic chambers 
were starved of NGF overnight (negative control, red box) and then treated with 200 
ng/ml NGF as described: NGF was added to the axonal networks (blue boxes), or added 
directly to cell bodies (positive control, green boxes). N=2. Cells per condition are 
shown in brackets under each column. n.s. not significant, *** p<0.001. Neurons were 
cultured in DRG complete medium, as previously described. 
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appeared downregulated in the somato-dendritic compartment of microfluidic cultures 
of E18.5 DRG neurons, compared to E14.5 DRG cultures. Surprisingly, receptor 
expression in the axonal side of microfluidic chambers is comparable in both E14.5 and 
E18.5 cells (Figure 2.27). Interestingly, p75NTR and Trk have two bands in the somal 
compartment: an upper band corresponds to the fully mature form of the protein, while 
a lower band represents receptor carrying high mannose N-glycans typical of proteins 
that have not completed their processing within the Golgi (Schecterson and Bothwell, 
2010). This second band cannot be observed in the axonal compartment. I could 
confirm by immunofluorescence that cell bodies of E18.5 DRG neurons express lower 
levels of the Trk receptor (Figure 2.27). 
 
Taken together, these results suggest that DRG sensory neurons are able to modulate the 
expression levels of neurotrophin receptors, and therefore respond differently to the 
same stimulus at different developmental stages. 
 
2.4.2 Phosphorylation of intermediates of the neurotrophin signalling cascade. 
I also tried to develop alternative read-outs to the CREB phosphorylation read-out. I 
analysed other intermediates in the signalling cascade initiated by neurotrophin binding 
to its receptors. Some of these intermediates have the advantage of being present in 
neurons at higher concentrations than CREB. This facilitates the study of their 
phosphorylation kinetics by methods such as western blot, since not so much initial 
material is required. Such an approach would facilitate the analysis of the response of 
neurons to neurotrophin treatments, because western blot is less time consuming than 
the image based CREB phosphorylation read-out. 
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Figure 2.27: Analysis of neurotrophin receptor expression. (A) Western blot 
analysis of lysates corresponding to the separate compartments in microfluidic 
chambers shows no remarkable differences in the expression of the p75NTR receptor 
(rabbit antibody α-p75NTR, intracellular portion) between E18.5 DRG and E14.5 DRG 
cultures (lower two panels). However, the Trk receptor (pan-Trk B3 antibody) appears 
downregulated in the somato-dendritic compartment (CB) of E18.5 DRG, compared to 
E14.5 DRG cultures (upper two panels). In both cases, two bands can be observed in the 
CB compartment: an upper band of mature protein and a lower band of not fully 
glycosylated receptor. This second band is absent in the axonal compartment (AX). (B) 
Tridimensional stacks of confocal microscope images corresponding to E18.5 and 
E14.5 DRG cultures in microfluidic chambers stained with a Trk antibody (pan-Trk 
B3). Cells were fixed with 4 % PFA and permeabilised with 0.1 % Triton X100 before 
staining. Neurons were cultured in DRG complete medium, as previously described. 
Scale bars: 10 µm. 
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For this purpose, I used P0 SCG and E14.5 DRG cultures to follow the phosphorylation 
of TrkA or Akt with phospho-specific antibodies upon NGF treatments (Figure 2.28). 
The levels of phosphorylation of these signalling intermediates after overnight 
starvation of growth factors were reduced to basal levels. NGF stimulation of cell 
bodies triggers the phosphorylation of both Akt and TrkA. 
 
These very preliminary results offer the proof of principle to show that this western blot 
approach could also constitute a valid method to study long-range effects of 
neurotrophin signals in microfluidic cultures of primary neurons. However, I have not 
performed an exhaustive optimisation for these particular experiments yet. 
 
2.4.3 MRTF-A does not translocate to the nucleus in response to NGF. 
I also tried to study additional downstream effects of the neurotrophin signalling 
cascade not necessarily related to CREB phosphorylation. The Serum Response Factor 
(SRF) transcription co-factor MAL (megakaryocytic acute leukemia), also known as 
MRTF-A, has been reported to translocate to the nucleus in response to NGF in DRG 
sensory neurons (Wickramasinghe et al., 2008). In cell lines, MRTF-A has been shown 
to translocate to the nucleus when cells are exposed to serum (Vartiainen et al., 2007). 
 
I first used spinal cord primary motor neurons in my experiments, but they failed to 
show any translocation of MRTF-A into the nucleus after treatments with the 
neurotrophin BDNF or horse serum. Moreover, MAL seemed constitutively cytosolic or 
nuclear depending on whether or not the neurons had been cultured in the presence of 
serum immediately after dissection and subsequent tissue dissociation. This distribution 
was unaffected by subsequent starvation or stimulation treatments (Figures 2.29 and 
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2.30). I also carried out time course experiments stimulating serum starved motor 
neuron mass cultures with BDNF or horse serum to determine if MRTF-A translocation 
could be happening at later time points. However, the protein remained cytosolic in all 
conditions tested (1-24 hours). 
 
Next, I carried out this experiment in E14.5 DRG cells, the same cell system used in the 
paper that described MRTF-A nuclear translocation upon neurotrophin treatment 
(Wickramasinghe et al., 2008). Surprisingly, in my experiments the protein remained in 
the cytoplasm even after long treatments with NGF (Figure 2.31). 
 
These results may indicate that neurotrophins are not directly responsible for causing 
the nuclear translocation of the transcription co-factor MRTF-A. They may instead 
stimulate an intermediate signalling mechanism, which is possibly lost in well-
established mature cultures. In any case, it was not possible to optimise a readout based 
on the translocation of MRTF-A to the nucleus in response to NGF treatments of DRG 
axonal networks in microfluidic chambers. 
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Figure 2.28: Western blot analysis of phosphorylated intermediates of the NGF 
signalling cascade. (A) Microfluidic cultures of P0 SCG cells (DIV8) were starved of 
NGF overnight, then both the somato-dendritic and axonal compartments were 
simultaneously exposed to 200 ng/ml NGF. After 20 minutes incubation, both sides 
were lysed in Laemmli buffer. These samples were run in a SDS-PAGE gel, transferred 
to a PVDF membrane and blotted for phosphorylated Akt (S473). CB, cell bodies; AX, 
axons. Note: total Akt would have been a more appropriate loading marker than α actin 
(B) E14.5 DRG cultures in microfluidic chambers were starved of NGF overnight, then 
treated as follows: with NGF for 10 minutes in both compartments (NGF, 10m, BC), 
with NGF for 2 hours in the axonal compartment (NGF, 2h, AX), or with medium 
lacking NGF (starved). Somato-dendritic (CB) and axonal (AX) samples were lysed in 
Laemmli buffer. Samples were run in SDS-PAGE, transferred to a PVDF membrane 
and blotted with antibodies against pTrkA (Y490) and pAkt (S473). Note: total Akt and 
total TrkA would have been more appropriate loading markers than β III tubulin. 
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Figure 2.29: Distribution of MRTF-A in spinal cord motor neuron cultures 
cultured in the absence of horse serum. E14.5 rat spinal cord motor neurons were 
plated in MatTek mass culture dishes in medium lacking serum immediately after 
primary cell preparation. At DIV7, neurons were starved of growth factors overnight 
and then exposed to medium with or without BDNF (BDNF and starved). BDNF 
treatment was maintained for 1 hour. An additional sample to determine MRTF-A 
distribution before starvation (fed) is also shown. Cells were fixed with 4 % PFA and 
stained with antibodies against MRTF-A and NeuN. Scale bars: 20 µm. 
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Figure 2.30: Distribution of MRTF-A in spinal cord motor neuron cultures 
cultured in the presence of horse serum. E14.5 rat spinal cord motor neurons were 
plated in MatTek culture dishes in serum-containing medium. At DIV5, neurons were 
starved of growth factors overnight, then exposed to medium with or without BDNF 
(BDNF and starved). BDNF treatment was maintained for 1 hour and an additional 
sample to determine MRTF-A distribution before starvation (fed) is also shown. 
Neurons were fixed in 4 % PFA and stained with MRTF-A and NeuN antibodies. Scale 
bars: 10 µm. 
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Figure 2.31: MRTF-A does not translocate to the nucleus in DRG neurons in 
response to NGF. E14.5 DRG neurons in microfluidic chambers (DIV6) were starved 
of NGF overnight and then exposed to medium with or without NGF (NGF and 
starved). NGF treatment was maintained for 8 hours. An additional sample to determine 
MRTF-A distribution before starvation (fed) is also shown. Neurons were fixed with 
4% PFA and then stained with the nuclear marker Hoechst and the MRTF-A antibody. 
Scale bar: 20 µm. 
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2.5 Transfection methods for overexpression of Rab7 mutants. 
 
Once the culture system and experimental readout had been established, a method was 
needed in order to impair Rab7 activity. Rab7 had been found to be a required factor for 
axonal retrograde transport (Deinhardt et al., 2006b). Abolishing Rab7 activity by 
introducing dominant negative mutants or downregulating Rab7 represents a valid 
strategy to tackle the relationship between neurotrophin signalling and axonal transport. 
However, the implementation of this strategy requires a reliable method to drive the 
expression of exogenous proteins or drive RNA interference against specific targets. 
Therefore my next goal was the optimisation of a suitable transfection method for 
neuronal cultures in microfluidic chambers. 
 
The Molecular NeuroPathobiology Laboratory had already optimised a microinjection 
protocol to transfect primary cultures of spinal cord motor neurons in mass culture. This 
method had limited utility with microfluidic chambers, since the microinjection needle 
could not reach the cells confined inside microfluidic chambers. Additionally, the 
laboratory had already tested magnetic and lipid-based transfection reagents and it was 
found that they interfered with normal membrane trafficking events, greatly affecting 
axonal retrograde transport. Therefore, alternative methods were tested. 
 
2.5.1 NanoJuice. 
NanoJuice is a non-lipidic reagent based on dendrimers technology. Dendrimers are 
large branched spherical polymers that have been recently found to be suitable gene 
delivery systems for cell transfection. They work similarly to lipid-based methods, but 
they have been marketed as particularly efficient with hard to transfect cells (i.e. 
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primary neurons). However, it was unknown how the reagent itself could affect 
membrane trafficking pathways. 
 
I tested NanoJuice with mass cultures of spinal cord motor neurons and obtained a RFP 
transfection yield of approximately 5% of neurons in optimal conditions (Figure 2.32). 
However, a yield of transfection of about 5% was not enough for my experiments in 
microfluidic chambers, since only a very low population of motor neurons extend 
projections into the axonal compartment. My attempts at transfecting spinal cord motor 
neurons inside microfluidic chambers failed to transfect neurons that projected axons 
into the axonal side. 
 
I also tried to transfect DRG sensory neurons in mass culture and microfluidic chambers 
with NanoJuice. After several attempts, no DRG neuron was found to express the RFP 
reporter, even when high transfection rates in glial cells could be observed. 
 
Because of the lack of success in obtaining a suitable yield of transfected neurons inside 
microfluidic chambers, NanoJuice was discarded as a transfection reagent. 
 
2.5.2 Electroporation. 
Several alternative transfection systems based on different biophysical principles have 
recently been introduced in the market. Electroporation tranfection methods are based 
on the application of an external electric field to increase the permeability of the plasma 
membrane and allow the exogenous DNA to enter the cell. I tried an electroporation 
approach with the CX1 System, Cellaxess (www.cellectricon.se), and used E14.5 DRG 
sensory neurons for this optimisation. The novelty in this electroporator apparatus 
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Figure 2.32: Transfection of motor neurons with NanoJuice. E14.5 rat spinal cord 
motor neurons (DIV9) cultured in coverslips were transfected with NanoJuice to 
express RFP (See Section 2.5.1 for details). After 24 hours, they were fixed with 4 % 
PFA and then imaged to determine transfection yield. Neurons were cultured in motor 
neuron complete medium, as previously described. Scale bar: 20 µm. 
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resides in its electroporator capillary, which carries built-in electrodes, as well as a 
reservoir and dispenser for the DNA solution. The head of this capillary can be 
immersed in culture medium and allows transfection of adherent cells without the need 
for any medium change, before of after electroporation. As before, I initially tried a 
simple transfection experiment to determine transfection yield in different conditions, 
and I then performed transport experiments after transfecting using conditions that had 
produced maximum transfection yields. Plasmid concentration was always 100 µg/ml. 
The different conditions depended on the range of voltages (240-320 V), and the 
number of electroporation pulses (2 or 3) used. 
 
Transfection efficiency was difficult to quantify, as only cells immediately under the 
transfection capillary can be transfected with this method. Unfortunately, only a limited 
amount of transfected neurons were found in any of the conditions tested. Axonal 
transport was observed in transfected cells and these transfected neurons seemed to 
internalise our fluorescent probes normally (Figure 2.33). 
 
Next, I tried to repeat this protocol with DRG cultures inside microfluidic chambers. In 
this system, neurons inside the lateral channels are out of the reach of the electroporator 
capillary head, but we were aiming at transfecting DRG neurons in the wells at both 
ends of the channel, that extended projections into the axonal compartment. I tested this 
method twice in microfluidic chambers, but no GFP-positive neurons were observed in 
our experiments. 
 
As with NanoJuice, this method had to be discarded because of the lack of compatibility 
with microfluidic chambers. 
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Figure 2.33: Transfection of DRG sensory neurons by electroporation. E14.5 DRG 
neurons (DIV5) in mass cultures (MatTek) were electroporated with GFP (See Section 
2.5.2 for details) and then exposed to 40 nM TeNT Hc coupled to AlexaFluor555. Cells 
were fixed with 4% PFA and stained with Hoechst nuclear marker. Neurons were 
cultured in DRG complete medium, as previously described. Scale bar, 10 µm. 
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2.5.3 Lentivirus transduction. 
I then decided to try a lentivirus-based approach approach to transduce neurons cultured 
inside microfluidic chambers. Lentivirus-mediated transduction is a more labour 
intensive method in the initial steps of vector preparation. However, once the virus has 
been prepared, frozen aliquots can be used repeatedly with no additional work required. 
This method also achieves in principle very high transfection yields, and almost 100 % 
transduction efficiency has been reported for cultures of primary neurons. An additional 
advantage is that this method can transfect neurons cultured in confined spaces, which 
is the case of microfluidic chambers. 
 
The main drawbacks of this method are the need for longer time frames of expression 
compared to acute transfections, and that in general the degree of expression is lower. 
Long times of expression can be a problem with toxic proteins, whereas low expression 
levels can impair dominant negative approaches. Furthermore, this method is hazardous 
for the operator (Pauwels et al., 2009). Lentivirus vectors are related to human HIV and 
despite having been rendered replication deficient upon cell infection by the removal of 
genes essential for the viral cycle, they can still infect all mammalian cells including 
human. It is therefore a requirement to work in Class 2 laboratory space, and to exert 
precaution when handling concentrated virus preparations. However, when all 
recommended safety procedures are followed, this is an ideal method to transduce hard 
to transfect neuronal cultures. 
 
I received a second-generation mCherryRab7WT virus as a gift from Dr Marino Zerial in 
the Max Plank Institute, Dresden (Germany) and performed point mutagenesis to 
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generate two types of dominant negative forms of Rab7, which have an impaired ability 
to bind GTP (mCherryRab7N125I and mCherryRab7T22N). Rab7T22N is often called the 
GDP-locked mutant, since it can only bind GDP and not GTP, whereas Rab7N125I is 
called the empty mutant, because it cannot bind either GDP or GTP (Papini et al., 
1997). Wild type and mutant forms were sequenced to confirm the presence of the 
desired mutations only (Figure 2.34). 
 
I initially tested the mCherryRab7WT viral particles from supernatants of packaging cells 
and although some glial cells expressed the construct, no motor neurons were 
transduced. I then introduced a concentration step in our virus preparation protocol by 
ultracentrifugation. These concentrated viral batches (at least 1.5*109 viral particles/ml) 
transduced spinal cord motor neuron cultures in microfluidic chambers very efficiently, 
transfecting almost all of the neurons in the culture. They were used at a multiplicity of 
infection (MOI) of 10 viral particles/neuron. It must be noted, however, that expression 
levels can vary significantly from cell to cell. 
 
Next, I tested this transduced cultures in transport experiments with fluorescently 
labelled tetanus toxin. I observed a high degree of variability in the colocalisation 
between overexpressed mCherryRab7WT and transported tetanus toxin in individual 
cells. In some cells there was only partial colocalisation, whereas in others no 
colocalisation between the toxin and mCherryRab7WT could be observed. This 
variability had not been previously reported and it might reflect the heterogeneity of our 
spinal cord cultures (Figure 2.35). The spinal cord motor neuron system was therefore 
discarded in later experiments. 
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Figure 2.34: Sequences of Rab7 wild type and mutants in lentiviral vectors. Wild 
type canine Rab7 was used as a template to produce our Rab7T22N and Rab7N125I 
mutants by directed mutagenesis. ACA = threonine, AAT = asparagine, AAC = 
asparagine, ATC = isoleucine. Sequencing reactions were performed by the Cancer 
Research UK Equipment Park Unit. 
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Figure 2.35: Colocalisation between TeNT Hc and mCherryRab7WT in motor 
neurons. TeNT Hc AlexaFluor488 was added to axon terminals of E14.5 rat spinal cord 
motor neurons (DIV12) expressing mCherryRab7WT in microfluidic chambers. 
Transport was imaged live 100-120 minutes after adding the probe. Representative 
kymographs are shown from movies in which partial (left panels) or no colocalisation 
(right panels) could be observed. 
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I then used virus concentrates on cultures of E14.5 DRG sensory neurons in 
microfluidic chambers. By immunofluorescence, the three forms of mCherryRab7 seem 
to be expressed at different levels (Figure 2.36). This level of overexpression also varies 
from cell to cell. Western blot analysis shows the level of mCherryRab7 expression 
compared to the endogenous expression of Rab7 (Figure 2.37). Immunofluorescence 
and western blot results indicate that the preparation of Rab7N125I viral preparation was 
not very successful and results obtained from samples infected with this viral construct 
will not be considered further. Both assays suggest that mCherryRab7WT and 
mCherryRab7T22N are expressed several times over the levels of the endogenous Rab7 
protein. 
 
Next, I used transduced cultures to assess their ability to sustain axonal retrograde 
transport of AlexaFluor488 TeNT Hc. This probe was transported in neurons expressing 
mCherryRab7WT. Surprisingly, transport was also observed in mCherryRab7T22N 
overexpressing cells. Axons of highly overexpressing cells were used for live cell 
imaging experiments (Figure 2.38). These results seem to contradict those of a previous 
report (Deinhardt et al., 2006b), in which it was suggested that axonal transport of 
TeNT Hc depended on the normal activity of Rab7 and could be blocked by 
overexpression of the Rab7N125I dominant negative mutant.  
 
Additionally, I examined the level of accumulation of TeNT Hc in cell bodies by 
immunofluorescence, as this could provide a good indication of functional axonal 
retrograde transport in mCherryRab7T22N expressing cells (Figure 2.39). Again, no 
significant differences could be appreciated between neurons expressing Rab7WT and 
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Figure 2.36: Overexpression of mCherryRab7WT and mutants in DRG neurons. 
E14.5 rat DRG sensory neurons in microfluidic chambers (DIV3) were incubated 
overnight with virus concentrates containing wild type and mutant versions of 
mCherryRab7 (Multiplicity of Infection: 10). Medium was changed the day after for 
normal DRG complete medium and neurons were imaged five days after transduction 
(DIV8). Scale bars: 20 µm. 
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Figure 2.37: Overexpression of mCherryRab7 constructs by western blot. Samples 
were obtained from E14.5 rat DRG neurons (DIV8) in microfluidic chambers infected 
with mCherryRab7 contructs five days before sample collection. Lysates were collected 
in 20µl Laemmli buffer, run in a SDS-PAGE, transferred to PVDF membranes and 
blotted with specific anti-Rab7 and Tuj1 antibodies. Second lane in the gel corresponds 
to the loading of the molecular weight marker. 
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Figure 2.38: Axonal retrograde transport of TeNT Hc in mCherryRab7T22N 
overexpressing DRG neurons. Axons of E14.5 rat DRG neurons (DIV9) in 
microfluidic chambers were incubated with 40 nM AlexaFluor488 TeNT Hc (axonal 
side) and transport was recorded in the microgrooves by live cell imaging confocal 
microscopy. Consecutive frames from a representative movie (A) and the kymograph 
representation for the same movie (B) are shown. 
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Figure 2.39: Accumulation of TeNT Hc in mCherryRab7-expressing DRG 
neurons. Axon terminals of E14.5 rat DRG neurons expressing mCherryRab7WT (left 
panels) or mCherryRab7T22N (right panels) in microfluidic chambers were exposed to 40 
nM AlexaFluor488 TeNT Hc (axonal side). Accumulation of the probe was observed in 
both wild type and mutant expressing cells. Scale bar: 20 µm. 
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the dominant negative mutant Rab7T22N. However, these results will have to be 
confirmed with a more quantitative biochemical method. 
 
2.5.4 CREB phosphorylation in lentivirus transduced cells. 
Despite the unexpected results obtained using TeNT Hc to assess axonal retrograde 
transport, DRG neurons transduced with Rab7T22N were used to test CREB 
phosphorylation upon NGF addition. Interestingly, I found that these neurons show 
impaired levels of CREB phosphorylation, both when NGF is added directly to cell 
bodies in cultures of DRG neurons inside microfluidic chambers or when NGF is added 
to the axonal side (Figure 2.40). 
 
Taken together, my results seem to indicate that Rab7 is indeed having a dominant 
negative effect in regards to the signalling cascade that results in the phosphorylation of 
CREB. These unexpected results were highly reproducible. However, further 
experiments are necessary to characterise the precise role of Rab7 in this process and 
the mechanism by which Rab7T22N block NGF-dependent CREB phosphorylation. 
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Figure 2.40: CREB phosphorylation in mCherryRab7T22N overexpressing neurons. 
Non-transduced E14.5 rat DRG neurons (DIV8) cultured in microfluidic chambers were 
used for a control experiment (A), which shows the normal response of these cells to 
NGF stimulations (200 ng/ml) from the axon terminals for 2 hours (blue box) or upon 
incubation with NGF in the somato-dendritic compartment for 10 minutes (green box). 
mCherryRab7T22N-overexpressing E14.5 rat DRG neurons (DIV8) cultured in 
microfluidic chambers (B) failed to respond to NGF stimulation from the axonal 
compartment (blue box) and responded less intensely to the direct stimulus (green box) 
when compared to the starved condition (red box). N=1. Cells per condition are shown 
in brackets under each column. n.s. not significant, *** p<0.001. Neurons were cultured 
in DRG complete medium, as previously described. 
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2.6 Lentivirus knock-down of endogenous Rab7. 
 
The results obtained with the dominant negative approach needed to be confirmed by 
other methods. Alternative strategies to the use of dominant negative Rab mutants are 
overexpressing specific GAP proteins or reducing the expression level of the 
endogenous protein by RNA interference. I chose to downregulate the levels of 
endogenous Rab7 with a lentiviral shRNA approach in E14.5 DRG sensory neurons. 
 
It was evident from the start that downregulation of Rab7 was toxic for these neurons, 
since this method induced caspase-mediated apoptotic cell death four days after cell 
transduction (Figure 2.41). Therefore, experiments were always carried out three days 
after lentiviral transduction. At this time point, only a minor fraction of cells has already 
undergone apoptosis and the axonal network in the axonal side of the microfluidic 
chamber seems intact and healthy. The reduction in the levels of Rab7 was assessed by 
western blot three days after viral transduction (Figure 2.42). Quantification by ImageJ 
Gel Analyzer indicates a reduction of 95% in the shRab7 treated cells over the 
endogenous Rab7 in the control. 
 
Once the reduction in endogenous Rab7 levels had been assessed, signalling 
experiments were carried out with these Rab7 deficient DRG neurons and they showed 
a defective response in terms of phosphorylation of the transcription factor CREB when 
these cells were stimulated with NGF either directly in the cell bodies or from the axon 
terminals in microfluidic chambers (Figure 2.43). 
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I then asked if these cells, which had shown a signalling defect, also suffered from 
impaired axonal retrograde transport. Therefore, axon terminals were exposed to 
fluorescently labelled TeNT Hc and this transport was tracked. Surprisingly, normal 
TeNT Hc transport was observed in Rab7 depleted cells (Figure 2.44). Again, this 
contradicted the results that had been expected, based on a previous report (Deinhardt et 
al., 2006b). 
 
I also looked at the accumulation of the probe in the cell bodies of DRG neurons after 
axonal retrograde transport in a qualitative manner. Accumulation of the probe looks 
very similar in transduced and control cells. Because the only source of toxin is coming 
from the axonal network, this is an indirect observation of retrograde transport (Figure 
2.45). However, more quantitative methods will be required to determine if there is any 
defect in the accumulation of the probe in cells bodies of Rab7 depleted neurons. 
 
Taken together, these results indicate that Rab7 plays an important role in regulating the 
neurotrophin signalling cascade that results in the phosphorylation of the transcription 
factor CREB, probably by maintaining normal late endosome membrane traffic 
pathways. The role of Rab7 in axonal retrograde transport pathways however deserves 
further investigation. 
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Figure 2.41: Apoptotic cell death in shRab7 transduced neurons. E14.5 rat DRG 
sensory neurons (DIV9) cultured in microfluidic chambers were incubated overnight 
with lentivirus carrying shRNA sequences targeting the endogenous rat Rab7 mRNA. 
Four days after transduction, apoptotic cell death can be observed in shRab7 treated 
cultures and not in shLuciferase controls. Staining with specific active caspase3 
antibodies provides evidence that this is a caspase-mediated process. Neurons were 
cultured in DRG complete medium, as previously described. Scale bar: 20 µm. 
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Figure 2.42: Rab7 downregulation and axonal network homeostasis. E14.5 DRG 
neurons (DIV6) cultured in microfluidic chambers were incubated with shRab7 virus 
overnight. (A) 15 µl Laemmli buffer lysates from the somal and axonal sides were 
obtained from these cultures at DIV9, pooled together and run in a SDS-PAGE, then 
transferred to a PVDF membrane and blotted with a rabbit anti-Rab7 antibody. (B) 
Axonal networks were imaged immediately before lysis to confirm their integrity. The 
lack of axonal swelling is indicative of healthy axons. 
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Figure 2.43: Time course of CREB phosphorylation in endogenous Rab7 depleted 
E14.5 DRG neurons. Rab7 depleted and control E14.5 rat DRG neurons (DIV9) 
cultured in microfluidic chambers were starved of growth factors overnight, and then 
treated with 200 ng/ml NGF directly in the cell bodies (CB), or in the axon terminals 
(AX). The experiment was repeated three times. In a third repetition shRab7 treated 
cells did not starve properly and the experiment was discarded. N=3. Two 
representative experiments are shown. Cells per condition are shown in brackets under 
each column. n.s. not significant, * p<0.05, ** p<0.01, *** p<0.001. Neurons were 
cultured in DRG complete medium, as previously described. 
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Figure 2.44: TeNT Hc transport in endogenous Rab7 depleted cells. AlexaFluor488 
TeNT Hc (40 nM) was added to axonal terminals of control and Rab7-depleted E14.5 
rat DRG neurons cultured in microfluidic chambers and transport was imaged in the 
microgrooves. The speed of transport seems largely unmodified by the lack of Rab7 as 
indicated by the similar slopes of the traces. Frequency of transport might be reduced in 
the Rab7-depleted sample. However, more quantitative methods are required to 
determine if there is a real defect in transport and accumulation of the probe in the 
neuronal cell bodies after axonal retrograde transport. Kymographs were constructed 
with Metamorph using transport movies from Rab7-depleted and control cells. Neurons 
were cultured in DRG complete medium, as previously described. 
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Figure 2.45: Accumulation of TeNT Hc in endogenous Rab7 depleted neurons. 
Axon terminals of shRab7 treated E14.5 rat DRG neurons (DIV9) in microfluidic 
chambers were exposed to AlexaFluor488 TeNT Hc (axonal side) three days after viral 
transduction. Healthy cells (a) as well as cell that have entered (b) or have already 
undergone apoptosis (c) were able to transport the probe from the axon terminals to cell 
bodies. Scale bars: 20 µm. 
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3.1 Microfluidics, a new device for compartmentalised cultures of primary 
neurons. 
 
Microfluidic devices have become increasingly popular in biology for a variety of 
applications. They have been adapted for their use as micro-PCR machines, protein 
crystallization screening chips and cell culture devices, to cite a few. The specific 
application discussed in this thesis, the use of microfluidic devices as culture platforms 
for primary neurons, provides a compartmentalised system in which neurons can be 
induced to preferentially grow their axons into a compartment that remains fluidically 
separate from the somal side. 
 
Other compartmentalised systems already existed. The most popular, which has been 
traditionally used in the study of long-range neurotrophin signalling, is the Campenot 
chamber (Campenot, 1977). Campenot chambers consist of a Teflon divider attached to 
a collagen-coated dish by a cushion of silicone grease. The collagen coat is scratched 
prior to assembly to create parallel grooves that allow axonal growth across the silicone 
grease barrier. 
 
Campenot chambers have major disadvantages when compared with microfluidic 
devices. An important problem results from the intrinsic variability in the final 
dimensions of Campenot chambers. The quality of the assembly of Campenot chambers 
depends critically on the skill of the operator (Campenot et al., 2009). Also, the 
procedure to prepare Campenot chambers is labour intensive and 30-50% of all finished 
devices need to be discarded because of leaking problems. Microfluidic chambers 
instead are copied against a mould and therefore they all share the same dimensions. 
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Additionally, when microfluidic chambers are assembled after plasma treatment, the 
seal is watertight and it never leaks. 
 
There are also functional differences between the two systems that need to be 
considered. The fluidic isolation provided by microfluidic chambers relies heavily on a 
tight control of fluid flow across the microgrooves. This control can be achieved by 
carefully considering the volumes to be loaded in the separate sides of the device. In 
contrast, users of Campenot chambers assume that fluidic isolation is achieved by a 
perfectly watertight separation between compartments. This has not been rigorously 
demonstrated (Campenot et al., 2009) and if true, it would be hardly possible for 
neurons plated in the cell body compartment to sense the growth factor gradients, which 
are used in axonal compartments to induce a preferential growth of axonal networks 
into them. Instead, it is highly likely that microscopic channels are present in the areas 
where the collagen coat of the Campenot chamber is scratched. If these microchannels 
are not taken into account when loading medium in the different compartments of a 
Campenot chamber, uncontrolled fluid flow could be directed into the compartment 
intended to remain in isolation. This can lead to results that cannot be reproduced in a 
different compartmentalised system, as will be discussed in section 3.2, this thesis. 
 
In terms of fabrication, I prepared my first moulds, also called masters, for microfluidic 
device fabrication using standard soft lithography protocols. These masters were 
produced as a relief of the UV light sensitive polymer SU-8 on silicon wafers. From the 
start, it was obvious that these masters only lasted a limited number of replica moulding 
repetitions, in which the mould is copied with polydimethylsiloxane (PDMS) to produce 
the actual microfluidic device. Masters failed because of one of two main problems: 
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either the SU-8 layer delaminated from the silicon wafer, or the silicon wafer itself 
broke. 
 
I found a solution in producing new moulds copied from the primary SU-8/silicon wafer 
masters. These secondary masters were produced in an epoxy resin, which is a sturdier 
material. These masters were more robust and resisted failure with repeated use, which 
meant that many copies could be produced featuring the exact same dimensions of the 
original masters made of SU-8/silicon. This method also facilitates the possibility of 
collaborations by sharing epoxy masters with other groups, who can then produce their 
own PDMS devices. There is also the possibility of commercialising the epoxy masters, 
and one could envision their use as equivalent to that of agarose gels, which need to be 
cast shortly before use. In this same way, PDMS pieces for microfluidic chambers can 
be cast immediately ahead of their use as cell culture devices. 
 
PDMS microfluidic devices have been commercially available since 2008. Millipore 
sells them under the name AXISTM axon isolation devices. These are the same pieces 
originally developed by Taylor et al. 2005. However, their elevated price makes them 
an expensive system for projects that require extensive optimisation. 
 
Optimisation of the system could apply to many different aspects. Microfluidic cultures 
of hippocampal and cortical neurons have already been described elsewhere (Taylor et 
al., 2005), and cultures of sensory and sympathetic neurons are described in this thesis. 
But cultures of other neuron types may require an optimisation step for the cultures to 
establish dense axonal networks. My attempts at establishing microfluidic cultures of 
spinal cord motor neurons failed due to the lack of suitable chemoattractants to drive 
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this process. The use of different neuron types may involve an optimisation step to find 
the right conditions that produce suitable axonal networks. 
 
One must also consider that cultures of primary neurons are hard to transfect, and 
conventional transfection methods based on lipid reagents may not produce high enough 
yields for some biochemical applications. This difficulty is enhanced by the fact that 
microfluidic chambers keep the cells isolated in an enclosed, not easy to access 
compartment. This already makes it hardly compatible with methods such as 
microinjection, ballistic gene gun transfection (O'Brien and Lummis, 2006) and 
electroporation. 
 
During my own transfection optimisation experiments, I found that lentiviral 
transduction (Tiscornia et al., 2006) offers a suitable system for high-yield gene 
delivery in microfluidic cultures of motor and sensory neurons. Alternatively, promising 
primarily results have been obtained using a recently developed magnetofection method 
(Fallini et al., 2010). Magnetofection could be a more suitable system to rapidly test 
constructs without the need of subcloning into lentiviral vectors, or when the use of 
viral infections is for whatever reason not allowed (i.e. lack of P2 laboratory space) 
(Pauwels et al., 2009). 
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3.2 The phosphorylation of CREB in different neuronal types. 
 
I chose to use the phosphorylation of the transcription factor CREB, as a read-out to 
determine the role of Rab7-mediated axonal retrograde transport in regulating the 
signalling cascade that the nerve growth factor (NGF) initiates upon binding to its 
receptors. These experiments were always performed in microfluidic cultures of 
primary neurons to ensure that only axon terminals were selectively exposed to 
neurotrophin treatments.  
 
Spinal cord motor neurons phosphorylate CREB in response to BDNF in mass cultures 
(Deinhardt et al., 2006b). Also sensory and sympathetic neurons have been shown to 
phosphorylate CREB both in response to NGF in mass cultures and when NGF is 
specifically added to axonal compartments in Campenot chambers (Riccio et al., 1997; 
Watson et al., 2001). Surprisingly, in my experiments I found that neither P0 Superior 
Cervical Ganglia (SCG) neurons nor E18.5 Dorsal Root Ganglia (DRG) neurons 
responded to NGF added to the axonal network in microfluidic chambers. In contrast, 
both types of neuron responded normally by phosphorylating CREB when cell bodies 
were directly exposed to NGF in mass cultures or in the somal side of microfluidic 
chambers. For both neuron types, phosphorylation levels were found to peak after 20 
minutes of neurotrophin addition, decreasing steadily afterwards. 
 
Sympathetic neurons were prepared and used as previously reported (Riccio et al., 
1997). They were obtained from rat P0 SCG and used at 10-15 DIV (days in vitro). The 
main difference therefore is not in the cells but in the culture system used: Campenot 
chambers as opposed to microfluidic chambers. 
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As explained in section 3.1, microfluidic chambers work based on carefully controlled 
fluid flows, which provide fluidic isolation for one of the compartments. These precise 
flows are achieved by loading controlled volumes of medium in the wells of the system.  
 
Instead, in Campenot chambers the importance of the volumes of medium loaded in the 
different compartments has often been overlooked. This may result in higher hydrostatic 
pressure in the side that is intended to remain in isolation, which is normally the NGF-
containing axonal side in long-range neurotrophin signalling experiments. This would 
direct a flow of NGF-rich medium into the somal compartment, and could possibly 
stimulate cells bodies directly and independently of axonal retrograde transport. If this 
is indeed the case, it can help to explain why the same experiment performed in 
microfluidic chambers and Campenot chambers could yield different results. 
 
In experiments with sensory neurons I explored the response to neurotrophins of 
neurons at different developmental stages. E18.5 DRGs failed to phosphorylate CREB 
in response to axonal NGF. However, E14.5 DRGs have been reported to phosphorylate 
CREB in response to neurotrophins applied to axon terminals (Watson et al., 2001). 
Therefore, I used E14.5 DRG neurons and found a different behaviour to what I 
observed for E18.5 cells. The peak of CREB phosphorylation for E14.5 neurons was 
observed at an earlier time point when cell bodies were stimulated directly with NGF 
and this peak was of higher intensity. More importantly, CREB was phosphorylated in 
these cells when NGF was added to axon terminals in microfluidic chambers. 
Interestingly, these developmental stages (E14.5 and E18.5) correspond to time points 
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before and after the period of critical neurotrophin dependence for DRGs in vivo, when 
physiological cell death occurs (Lonze et al., 2002). 
 
I tried to explore the differences between E18.5 and E14.5 DRG neurons that could 
explain these results and found that the expression levels of the Trk receptor were 
greatly diminished in the somal side of E18.5 microfluidic cultures by western blot 
analysis compared to E14.5 cultures, even when the expression levels of the receptor in 
the axonal terminals was approximately the same in both cases. This was confirmed by 
immunofluorescence studies, in which DRG cell bodies from E18.5 embryos stained 
less intensely than E14.5 DRG neurons using the same Trk antibody. 
 
It is still not clear how this can account for the lack of response in terms of 
phosphorylation of CREB when NGF is added to axon terminals in microfluidic 
chambers, as it seems counterintuitive that neurons with similar expression levels of Trk 
in axons would respond differently to axonal NGF while they still phosphorylate CREB 
when NGF is added directly to the cell bodies. 
 
It seems possible that at a certain developmental stage, Trk receptors in the soma could 
be necessary for a functional neurotrophin signalling cascade initiated from axon 
terminals. Axonal Trk receptors would be internalised upon ligand binding and 
transported to the cell bodies but would not be fully capable of triggering by themselves 
downstream effects such as CREB activation. For this, retrogradely transported NGF 
should have access to the soma population of Trk receptors by a transcytotic 
mechanism. Axonal Trk receptors would still respond locally to NGF and this would be 
reflected in the equal ability of axons of both E18.5 and E14.5 DRG neurons to respond 
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to chemoattracting gradients of NGF in microfluidic chambers and grow preferentially 
towards them. 
 
In this model, a threshold of activated ligand-receptor pairs would be necessary to 
trigger a response. Trk receptor expression levels in E18.5 DRG neurons would be 
enough to respond to NGF applied directly to the soma, but they would form a number 
of ligand-receptor pairs below threshold when NGF is applied to the axon terminals. 
This would also mean that when directly exposed to NGF, E18.5 DRG neurons would 
form a lower number of ligand-receptor pairs because of the lower number of Trk 
receptors available. Therefore, a less intense response upon NGF treatments is expected, 
as is the case. 
 
This transcytosis model would complement and expand the signalling endosome model 
in that the incoming carrier does not need to bring all signalling molecules from the 
axon terminal, but a functional signalling cascade can be reconstituted on the somal 
plasma membrane. This model remains to be tested and it is not clear whether it would 
constitute a general mechanism or if it would only apply to this specific neuronal 
population at a defined developmental stage. 
 
I could observe profound differences in the signalling responses to neurotrophins 
between different neuronal types, not only in terms of CREB phosphorylation, but also 
when studying other intermediates of the signalling cascade, such as Akt. Akt basal 
phosphorylation levels at Ser473 are very high in cell bodies of E14.5 DRG neurons. 
This was not the case for P0 SCG neurons, which showed low levels of basal Akt 
phosphorylation after overnight starvation. 
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The fact that key signalling intermediates may have radically different basal activation 
states may help us to understand how different neuron types, or the same type at 
different developmental stages, may not respond in the same manner (i.e. 
phosphorylation of CREB) upon receiving the exact same stimulus. This has to be 
understood in the context of the elaborate network of interactions in which neurotrophin 
receptors participate and the different levels at which the signalling cascade can be 
regulated. It suggests that one must carefully consider what model neuronal type and 
culture could be best to study specific aspects of neurotrophin signalling pathways. 
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3.3 The phosphorylation of CREB and Rab7 activity. 
 
E14.5 DRGs were the only neurons I tested where CREB is phosphorylated in response 
to NGF added to axon terminals. Therefore, they were chosen as the more suitable 
culture system to determine whether CREB phosphorylation was under the control of 
Rab7-dependent axonal retrograde transport (Deinhardt et al., 2006b). 
 
I initially used a dominant negative approach, in which I tried to overexpress a mutant 
form of Rab7, which has an aminoacid substitution in the GTP/GDP binding pocket 
causing a loss of function (or dominant negative) phenotype. I initially aimed at 
producing both the Rab7N125I and the Rab7T22N mutations. Rab7N125I is sometimes called 
the empty mutant, as it cannot bind either GTP or GDP. Rab7T22N, on the other hand, is 
referred to as the GDP-locked mutant, as it only binds to GDP (Papini et al., 1997). 
DNA preparations for both mutants using mCherry-Rab7WT as a template were 
successful and sequences confirmed that the expected mutations were present. 
However, my preparation of mCherry-Rab7N125I viral particles failed to overexpress 
adequate levels of the exogenous protein, when used to transduce DRG sensory neurons 
in microfluidic cultures. Therefore, only results obtained with the mCherry-Rab7T22N 
were considered. 
 
The Rab7T22N mutant has been reported to interfere with the correct intracellular 
trafficking and signalling of the NGF receptor TrkA (Saxena et al., 2005). These 
researchers found that PC12 cells transfected with GFP-Rab7T22N showed an increase in 
endosomal accumulation of TrkA, an increase in neurite outgrowth and sustained 
phosphorylation of TrkA and Erk1/2 (their time points are 2, 6 and 24 hours). In 
Chapter 3. Discussion
 
 
Page 149 
contrast, Akt phosphorylation remains unaffected. Using this same mutation, my 
experiments showed a reduction in the phosphorylation of the transcription factor 
CREB when E14.5 DRG neurons were directly exposed to NGF, and phosphorylation 
was abolished when NGF was added to axonal terminals. This could indicate that 
blocking endosomal maturation, which relies on Rab5 to Rab7 conversion (Rink et al., 
2005; Spang, 2009), by means of GDP-locked Rab7 overexpression results in an 
accumulation of signalling endosomes at a middle point of endosomal transport. This is 
likely to affect the signalling capabilities of Rab7-positive late endosomes, which could 
explain why CREB phosphorylation was diminished. 
 
Late endosomes have been found to play important roles in the sustained activation of 
the MAPK signalling cascade (Sadowski et al., 2009; von Zastrow and Sorkin, 2007). 
p14 is a scaffolding protein present in late endosomes that is required for the 
recruitment of MP1 (MEK1 partner 1). Epidermis-specific p14 conditional knockout 
mice have been used to demonstrate the essential role of the p14-MP1-MEK1 complex 
in skin development (Teis et al., 2006). PDZ-GEF1 is a Rap1 GEF (GDP/GTP 
exchange factor), which forms a tetrameric complex with the Trk receptor, 
Kidins220/ARMS (kinase D interacting substrate of 220 kDa/ ankyrin repeat-rich 
membrane spanning) and the scaffolding protein S-SCAM (synaptic scaffolding 
molecule), in vesicles that are positive for Rab7. This complex has been found to be 
required in PC12 cells for sustained Rap1 and Erk activation and for neurite outgrowth 
(Hisata et al., 2007). 
 
An alternative approach was used to confirm these results and I chose to knockdown 
endogenous Rab7 using shRNA lentiviral transduction. Rab7 knockdown proved toxic 
Chapter 3. Discussion
 
 
Page 150 
for neurons, which entered caspase-mediated apoptosis four days after lentiviral 
infection. Caspase-mediated apoptosis could be avoided in future experiments with pan-
Caspase inhibitors (i.e. Boc-D-FMK or Z-VAD-FMK). 
 
Therefore, experiments were always carried out three days after infection to avoid the 
problem of apoptotic cell death. Levels of Rab7 in E14.5 DRG neurons were reduced by 
95%, measured by western blot at this time point. CREB phosphorylation was analysed 
in Rab7 depleted cells in response to NGF treatments. Rab7 knockdown was found to 
completely abolish CREB phosphorylation when NGF was added to the axonal side of 
microfluidic chambers. Interestingly, it greatly diminished the intensity of the 
phosphorylation signal when cell bodies were exposed directly to the neurotrophin. 
Because of this, it is not possible to explain the loss of CREB phosphorylation when 
NGF is added to axon terminals in terms of a reduction of Rab7-mediated axonal 
transport. However, this result points again in the direction of an essential role for late 
endosomes in the signal transduction pathway that results in the activation of this 
transcription factor.  
 
To test this hypothesis, one needs to develop a more dynamic method to follow CREB 
activation in real time. My approach involved observing phosphorylation levels by 
immunofluorescence at specific time points when cells were fixed. This method was 
labour intensive and lacked proper dynamic information. However, a recent report has 
described a FRET-based approach, which allows monitoring CREB activation in real 
time. Friedrich and colleagues have developed a construct containing the KID domain 
of CREB fused to CFP and the KIX domain of CBP bound to YFP. KID and KIX are 
the domains of the proteins that interact upon CREB Ser133 phosphorylation (Lonze 
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and Ginty, 2002; Mayr and Montminy, 2001). Upon activation, the KID and KIX 
domains would interact, bringing the fluorescent proteins together (Friedrich et al., 
2010). 
 
An alternative approach consists of using the gene for the firefly luciferase under the 
control of the CRE promoter. Such an approach has already been successfully 
developed in an animal model (Böer et al., 2007). DRG neurons or other neuronal types 
from embryos of these mice cultured in microfluidic chambers would allow us to 
directly visualise the expression of the reporter gene in response to axonal treatments 
with neurotrophins. 
 
The main advantage of these approaches would be clarifying whether impairment of 
Rab7 activity (either by overexpression of a dominant negative or depletion of the 
endogenous protein) completely abolishes the phosphorylation of CREB or rather 
simply modifies its kinetics of activation (i.e. delaying the peak of activation to later 
time points). This is a change that would be difficult to observe using my experimental 
approach. These readouts offer the added advantage of being less time-consuming than 
quantifying the intensity of activation from immunofluorescence microscope images. 
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3.4 The role of Rab7 in axonal retrograde transport. 
 
In addition to CREB phosphorylation signalling experiments, mCherry-Rab7T22N-
expressing DRG neurons were used to monitor the axonal retrograde transport of TeNT 
Hc (Lalli and Schiavo, 2002) and confirm that a mutation in Rab7 caused a reduction in 
axonal retrograde transport. Previous work had shown that GFP-Rab7N125I 
overexpression by microinjection in spinal cord motor neurons completely abolished 
axonal retrograde transport of TeNT Hc (Deinhardt et al., 2006b). Surprisingly, the 
retrograde transport of TeNT Hc could still be observed in mCherry-Rab7T22N-
expressing DRG neurons. I tried to reproduce the previous results using mCherry-
Rab7N125I, but a lentiviral preparation carrying this mutant failed to achieve appropriate 
levels of overexpression. Instead, these experiments were repeated with DRG neurons 
that had been depleted of endogenous Rab7 using a lentiviral mediated shRNA 
approach. TeNT Hc transport experiments in this system failed to show the expected 
block in axonal transport. Moreover, Rab7 depletion caused apoptotic cell death. 
Interestingly, TeNT Hc was found to accumulate in DRG neurons with elevated levels 
of activated caspase-3, as well as in healthy cells. 
 
A plausible explanation for this discrepancy would suggest that GFP-Rab7N125I 
overexpression is sequestering an essential factor for retrograde transport, which is not 
depleted in cells overexpressing Rab7T22N. Interestingly, Rab7 has been found to be an 
interacting partner of the class III PI3K Vps34 (Stein et al., 2003). Immunoprecipitation 
studies using BHK-21 (baby hamster kidney) cells cotransfected with p150 (regulatory 
subunit of Vps34) and various forms of Rab7 (wild type, GTP-locked, GDP-locked and 
empty mutants) showed that only Rab7N125I is able to significantly sequester p150. In 
Chapter 3. Discussion
 
 
Page 153 
this same study overexpression of Rab7N125I or downregulation of Vps34 abolished 
delivery of the VSV-G (vesicular stomatitis virus glycoprotein) protein to late 
endosomes. 
 
More quantitative methods will be needed to determine whether overexpression of 
Rab7T22N or downregulation of the endogenous protein may have a detectable effect in 
the accumulation of any of the axonal transport probes I have used, and confirm or 
exclude a direct role for Rab7 in at least a fraction of retrograde transport carriers. In 
any case, the combination of my own findings and results reported by our group and 
others seem to indicate that Vps34-p150 and its products PtdIns(3)P and PtdIns(3,5)P2 
may play an important role in the onset or progression of axonal retrograde carriers. 
Interestingly, conditional knockout mice in which Vps34 has been deleted in sensory 
neurons show a disruption of the endocytic pathway and rapid neurodegeneration (Zhou 
et al., 2010). DRG neurons from these mice show an accumulation of endocytic 
structures that can be labelled with anti-Rab5 and anti-Rab7 antibodies, suggesting that 
there is deficient maturation of endosomal structures. 
 
This hypothesis could be tested using methods similar to those previously described for 
Rab7. Kinase inactive Vps34 dominant negative mutants have already been described 
(Stein et al., 2005; Stein et al., 2003). The use of these mutants in combination with 
shRNA mediated knockdown of the endogenous protein and the use of 3-methyladenine 
(3MA), which is a specific inhibitor for Vps34 (Hailey et al., 2010; Lindmo and 
Stenmark, 2006) could establish to what extent axonal transport depends on a functional 
phosphoinositide remodelling machinery.  
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3.5 Transcytosis and the neurotrophin signalling cascade. 
 
The intracellular sorting of neurotrophin and neurotrophin receptor-containing vesicles 
after axonal retrograde transport remains poorly understood. Moreover, there is some 
debate in the field as to what is the exact nature of the transport carriers themselves. 
Evidence has been presented showing that these structures carry markers of early 
endosomes (Delcroix et al., 2003), while other studies seem to indicate a role for Rab7-
positive late endosomes (Deinhardt et al., 2006b). Regardless of whether early or late 
endosomes are being transported, sorting decisions must be made for cargo once it 
reaches the cell soma. Some cargo might be directed towards the lysosome for 
degradation. Other cargo could be recycled back to the plasma membrane through the 
perinuclear endocytic recycling compartment (ERC), and finally material can also be 
retrieved to the trans Golgi network (TGN). Members of the sorting nexin family of 
proteins (Cullen, 2008) are very likely to be involved in regulating these sorting steps. 
 
I followed the retrograde transport of the general neurotrophin receptor p75NTR from 
axon terminals to the neuron soma and found that a significant fraction of the 
transported protein reached the plasma membrane. It remains to be determined whether 
this happens via a transcytotic pathway through the ERC, or whether the protein is first 
transported towards the TGN and redirected from there towards the secretory pathway. I 
found that part of these receptors can be re-internalised after being exposed at the 
plasma membrane and reach EEA1-positive structures, which are likely to be early 
endosomes. The physiological importance of this transcytotic route in long-range 
neurotrophin signalling remains to be understood. It would be interesting to elucidate 
Chapter 3. Discussion
 
 
Page 155 
whether neurotrophins and the Trk receptors follow a similar route or whether this is a 
specific p75NTR pathway. 
 
In order to explore further this trafficking mechanism, one could follow the retrograde 
transport and somato-dendritic sorting of a labelled form of a neurotrophin. Recently, 
NGF coupled to quantum dots (NGF-QD) has been used to determine the neurotrophin 
content of signalling endosomes, which apparently carry a single copy of NGF-QD 
dimer per endosome (Cui et al., 2007). However, caution must be used when adopting 
such a probe for intracellular trafficking studies, as QDs can alter the natural sorting 
pathways of the probes they are conjugated to (Tekle et al., 2008). 
 
Alternatively, developing a Trk receptor antibody that recognises the extracellular 
portion of the Trk receptor without interfering with neurotrophin binding could be used 
in experiments similar to those described in this thesis with the p75NTR directed against 
the extracellular portion of the protein. This can also be done with already existing HA 
tagged versions of the Trk receptor in combination with labelled anti-HA antibodies. 
 
This could be of importance in the context of long-range neurotrophin signalling, since 
activated ligand-receptor pairs are actively transported from axon terminals towards the 
neuronal cell body. Once they reach the plasma membrane, these pairs could potentially 
reinitiate plasma membrane-specific signalling events. However, a direct link between 
the transcytosis of p75NTR and neurotrophin signalling has not yet been established. 
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3.6 Concluding remarks and future perspectives. 
 
This project has established E14.5 DRG neuronal cultures in microfluidic chambers as a 
model system in the study of the long-range neurotrophin signalling cascade, 
responsible for the phosphorylation of the transcription factor CREB. This system is an 
improvement over existing compartmentalised cultures in Campenot chambers, which 
can be leaky, invalidating the premise of fluidic isolation between compartments. 
 
I optimised a CREB phosphorylation readout in response to neurotrophin treatments of 
axonal networks, which I found to be developmental stage-dependent in DRG sensory 
neurons. However, it has not been possible to establish a direct correlation between the 
activation of CREB and Rab7-dependent axonal retrograde transport. I showed that 
overexpression of a Rab7 dominant negative mutation, Rab7T22N, and down-regulation 
of endogenous Rab7 impaired the ability of E14.5 DRG neurons to phosphorylate 
CREB in response to neurotrophin treatments in cell bodies or distal axons. The 
involvement of Rab7 in this context deserves further investigation as it may constitute a 
general mechanism for all receptor tyrosine kinase signalling pathways. 
 
Surprisingly, impairment of Rab7 activity failed to abolish axonal retrograde transport 
of TeNT Hc. Interestingly, the Rab7N125I mutation that had been reported to block 
retrograde transport sequesters the p150 regulatory subunit of the class III PI3K Vps34, 
suggesting this phosphoinositide modifying enzyme might play an important role in this 
pathway. Microfluidic chambers are an ideal system in which to study whether or not 
this is the case. 
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4.1. Materials. 
 
4.1.1 Chemicals. 
Standard chemicals (i.e. Tris base, etc.), which are not listed below were purchased 
from Sigma-Aldrich. Molecular biology reagents were purchased from Invitrogen, 
Molecular Probes and New England Biolabs unless stated otherwise. 
 
4.1.2 Antibodies. 
Antigen Host Provider Dilution 
MAP2 Rabbit Chemicon Int 1:500 (IF) 
SMI 31 Mouse Covance 1:500 (IF) 
Tuj 1 (β III tubulin) Mouse Covance 1:1000 (IF), 1:1000 (WB) 
pCREB Rabbit Cell Signaling 1:500 (IF) 
NeuN Mouse Chemicon Int. 1:200 (IF) 
Trk(B3) Mouse Santa Cruz 1:1000 (IF), 1:1000 (WB) 
IC p75NTR (5081) Rabbit In house 1:1000 (WB), 1:200 (LCI) 
EC p75 NTR (5410) Rabbit In house 1:1000 (IF), 1:200 (LCI) 
pAkt (S473) Rabbit Cell Signaling 1:1000 (IF) 
α actin Rabbit Abcam 1:500 (WB) 
pTrkA (Y490) Rabbit Cell Signaling 1:1000 (IF) 
MRTF-A Goat Santa Cruz 1:100 (IF) 
TGN38 Mouse Gift, Dr S. Tooze 1:1000 (IF) 
Rab7 Rabbit Cell Signaling 1:100 (WB) 
Caspase 3 Active Rabbit R&D systems 1:500 (IF) 
IF: immunofluorescence; WB: western blot; LCI: live cell imaging. 
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Secondary antibodies were AlexaFluor488, 555 or 647-conjugated (Molecular Probes) 
for immunofluorescence or HRP-conjugated (Amersham Bioscience) for western blot. 
 
4.1.3 Constructs. 
4.1.3.1 mCherryRab7. 
Plasmids for overexpression of mCherryRab7 were a gift from Dr Marino Zerial, Max 
Planck Institute, Dresden, Germany: PAX, VSV-G (second generation lentivirus 
packaging plasmids) and mCherryRab7WT (it contains canine Rab7). 
• Oligonucleotides (for directed mutagenesis): 
Rab7 N125I fw ccctttcgttgtgttgggaatcaagattgacctcg 
Rab7 N125I re cgaggtcaatcttgattcccaacacaacgaaaggg 
Rab7 T22N fw ggagattctggagttggtaagaattcactcatgaaccagtatgtg 
Rab7 T22N re  cacatactggttcatgagtgaattcttaccaactccagaatctcc 
• Oligonucleotides (for sequencing): 
SEQ Lenti fw  ggacatcacctcccacaacgaggactacacc 
SEQ Lenti Rab gttacaatgcagatctgggacacagcaggcc 
SEQ Lenti re  gcatgatacaaaggcattaaagcagcgtatccac 
SEQ Lenti mC1 gctcacaacccctcactcggcgcgccagtcctcc 
SEQ Lenti mC2 cctccctgcaggacggcgagttcatctacaaggtg 
 
4.1.3.2 Rab7 shRNA. 
Empy plasmid (pLKO.1) was a gift from Dr Gordon Peters, Cancer Research UK 
London Research Institute. Primers are designed to target rat Rab7 mRNA. These 
primers have ends compatible with the restriction sites Age1 and EcoR1. 
• Oligonucleotides (for shRNA production): 
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shRab7 fw01  ccgggcccttaaacaggaaacagaactcgagttctgtttcctgtttaagggctttttg 
shRab7 re01  aattccaaaaagcccttaaacaggaaacagaactcgagttctgtttcctgtttaagggc 
shRab7 fw02  ccggtgctgtgttctggtgtttgatctcgagatcaaacaccagaacacagcatttttg 
shRab7 re02  aattccaaaaatgctgtgttctggtgtttgatctcgagatcaaacaccagaacacagca 
shRab7 fw03  ccgggaagttcagtaaccagtacaactcgagttgtactggttactgaacttctttttg 
shRab7 re03  aattccaaaaagaagttcagtaaccagtacaactcgagttgtactggttactgaacttc 
 
4.1.4 Cell lines and primary neurons. 
HEK293T cells (ATTC cat. No. CRL-1573) were used to produce lentivirus. Primary 
neurons were obtained from Sprague-Dawney rat embryos or pups. Pregnant females 
were purchased from Charles River. 
 
4.1.5 Medium for primary neurons. 
50 ml of bare-bones (BB) medium were prepared fresh each week. The volumes to be 
used for the various cultures were supplemented with 200 ng/ml NGF for dorsal root 
ganglia (DRG) and superior cervical ganglia (SCG) neurons, or with 10 ng/ml CNTF 
plus 100 pg/ml GDNF for spinal cord motor neurons. 
For 50 ml of BB medium: 
Neurobasal medium (Gibco) 48.6 ml 
B27 supplement (Gibco) 1 ml 
L-glutamine (in house) 104 µl 
2-Mercaptoethanol, 1 mM 1.25 µl (from 7:100 dilution) 
Penicillin/streptomycin, 5 µg/ml (in house) 250 µl 
Cytosine arabinoside, Ara-C, 5 µM 50 µl 
 
Chapter 4. Materials and methods
 
 
Page 161 
4.1.6 Microfluidic chambers. 
4.1.6.1 Materials for masters. 
SU-8 MicroChem, MA www.microchem.com 
Silicon wafers Compart Technology, UK www.compart-tech.com 
EC solvent Chestec, UK www.chestech.co.uk 
Photomasks JD photo, UK www.jdphoto.co.uk 
 
The epoxy resin was made up of components, which were purchased from Taab 
(www.taab.co.uk): MNA (Methyl Nadic Anhydride - Taab code M010); DDSA 
(Dodecenyl Succinic Anhydride - Taab code D014); DMP-30 (2.4.6-tri (Dimethyl 
aminomethyl) Phenol - Taab code D024); Taab 812 Resin (Taab code T022). 
Components were mixed in the following proportions (Table 2.I) 
Table 2.I: Quantities of components for EPON resin preparation. 
Taab 812 
RESIN (g) 
MNA (g) DDSA (g) 
ACCELERATOR 
DMP-30 (g) 
FINAL 
WEIGHT (g) 
9.6 6.6 3.8 0.4 20 
19.2 13.2 7.6 0.8 40 
28.8 19.8 11.4 1.2 60 
38.4 26.4 15.2 1.6 80 
48 33 19 2 100 
 
4.1.6.2 Materials for PDMS devices. 
Polydimethylsiloxane (PDMS, also known as Sylgard 184) was from Dow Corning. 
Glass bottomed WillCo petri dishes, 50 mm diameter were from IntraCel, UK. 
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4.2. Methods. 
 
4.2.1 Fabrication of SU-8 masters by soft lithography. 
A 3-inch diameter silicon wafer was spin-coated with a 3 µm thick layer of SU-8 
photoresist, using a spin-coater at 2000 rpm for 1 minute. The wafer was then prebaked 
at 95°C for 2 minutes and covered with a photomask. This photomask has a printed 
pattern that corresponds to the microgrooves in the finished device. The covered layer 
of SU-8 was then exposed to UV light (365 nm) for 2 seconds. A subsequent post-
exposure bake treatment (95°C, 1 min) was necessary to complete the polymerisation 
reaction of the UV irradiated photoresist. Finally, the patterned wafer was immersed in 
a bath of propyleneglycol methyletheracetate, better known by its commercial name EC 
solvent, which dissolved un-crosslinked SU-8 photoresist. The next step consisted of a 
repetition of this process, this second time spinning a 150 µm layer of SU-8 onto the 
previously patterned silicon wafer. This wafer was prebaked (95°C, 30 mins) and 
covered with a second photomask, which had the pattern corresponding to the lateral 
compartments in the device. This was irradiated with UV light (365 nm) for 8 seconds. 
Post-exposure bake was done at 95°C for 12 minutes. Un-polymerised SU-8 photoresist 
was removed with EC solvent. The final product was a SU-8/silicon mould, referred to 
as the master, which could already be used to produce PDMS devices. For further 
details, please see Park et al. 2006. 
 
4.2.2 Replica moulding. 
PDMS pieces were produced by mixing the base component of polydimethylsiloxane 
with curing agent (mixed 10:1, according to manufacturer instructions). This liquid 
mixture was put under vacuum to eliminate bubbles for approximately 30 minutes and 
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then poured on masters. These were put in an oven at 65°C for the PDMS to harden. 
PDMS devices were then peeled from masters and cut to their final shape. For this we 
used a 28 mm diameter Wad Punch (Roebuck) to cut the outer border. Finally four 
wells were cut, one at each end of each of the two lateral compartments. These wells 
were cut with a 5 mm borer. Alternatively, a biopsy punch (www.biopsypunch.com/) 
can be used. The final device was assembled after plasma treatment of both the PDMS 
insert and the glass-bottom dish (or a PDMS slab for specific applications, i.e. electron 
microscopy). Microfluidic chambers must be incubated at 65°C for 5 minutes to 
complete the binding reaction. Plasma treatment renders the surface of PDMS 
hydrophilic but this is not a stable modification. Therefore, coating must be applied 
immediately after chamber assembly. Alternatively, chambers can be filled with sterile 
distilled water and kept for future use. The plasma treatment alone is sufficient to 
sterilise microfluidic devices. 
 
4.2.3 Fabrication of epoxy masters. 
All components of the epoxy resin were mixed and the liquid mixture was kept under 
vacuum for at least 30 minutes to remove air bubbles. This was poured onto a tin cup 
and a PDMS microfluidic chamber copied from the model SU-8/silicon master was 
used as a mould. The PDMS device was set to float on the liquid mix of epoxy resin 
with the pattern facing downwards. The epoxy resin was polymerised at 65°C 
overnight. The PDMS mould was then peeled from the hardened epoxy block. A first 
PDMS device produced by replica moulding from these new masters was inspected 
under a light microscope to confirm that all dimensions of the original design were 
copied. 
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4.2.4 Motor neuron culture preparation. 
Spinal cord motor neurons were cultured in cover slips, glass bottom MatTek dishes, or 
microfluidic chambers treated with two consecutive coatings. First, culture platforms 
were coated with a solution of 15 µg/ml poly-ornithine (Sigma, P-8638) in sterile water, 
which was incubated at room temperature for a minimum of two hours. After this, the 
poly-ornithine solution was aspirated and the cell culture devices coated with a solution 
of 0.33 µg/ml laminin (Sigma, L-2020) in Neurobasal medium. This second coating was 
incubated at 37°C, 7.5% CO2 for a minimum of two hours. Immediately before plating 
cells, the laminin coating solution was removed and replaced with complete motor 
neuron culture medium in the case of cover slips and MatTek dishes. Microfluidic 
chambers were left empty and medium was added after plating the cells. 
 
E14.5 rat embryos were used for these dissections. Head and tail of the embryo were 
removed using two straight end number 5 jeweller forceps (Osborn & Simmons, Ltd 
OS.56/5). The skin in the back was peeled open, which exposed the spinal column. This 
was then cut open by its dorsal end, then lifted and detached from the embryo. The 
dorsal horn was removed with a scalpel, and only the ventral part of the spinal cord was 
kept for further dissociation. 
 
Several spinal cords from wild type rat embryos were typically pooled together and 
triturated with a scalpel. They were then transferred to a 15 ml Falcon tube with 1 ml 
PBS (phosphate buffered saline) and digested with 0.025% trypsin (Sigma, T-1426) for 
10 minutes in a water bath at 37°C. During incubation, a DNAse (Sigma, DN-25) mix 
was prepared in a separate 15 ml Falcon tube (800 µl L-15 medium, 100 µl 4% BSA, 
100 ml DNAse 1 µg/ml). Immediately after trypsin digestion, the spinal cord fragments 
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were transferred into the DNAse-containing tube and triturated with a P-1000 pipette 
tip. They were then incubated at 37°C for 15 minutes. After DNAse digestion, a 4% 
BSA cushion was applied to the bottom of the Falcon tube and cells were centrifuged at 
370g for 5 minutes at room temperature. Supernatant was discarded and the pellet was 
resuspended in L-15 medium (200 µl) per spinal cord. This preparation typically 
yielded 1-2 106 cells per spinal cord. 
 
5 µl of this concentrated cell suspension was suitable for plating approximately 50000 
cells on cover slips. 10 µl were needed for a single glass bottomed MatTek dishes. For 
microfluidic cultures, 10 µl cell-free medium was loaded in what was going to be the 
axonal side of the chambers. Immediately after, 9 µl cell suspension were loaded in the 
cell body compartment. In microfluidic chambers, any fluid has to be carefully applied 
with the pipette tip at the border of the entrance to the lateral channel, to prevent cells 
from attaching to the bottom of the loading wells only. One hour after plating, the 
microfluidic chamber was filled up with complete motor neuron culture medium (100 µl 
per well). Medium was typically changed once a week. Drying can be avoided by 
adding sterile water to the microfluidic chamber, outside of the PDMS device. 
 
4.2.5 Dorsal Root Ganglia (DRG) neuron culture preparation. 
Both E14.5 and E18.5 rat embryos were used for DRG preparations, and the procedure 
is the same at both developmental stages. A pair of number 5 straight end forceps were 
used, to remove head and tail of the embryo. The skin in the back was peeled open, 
which exposed the spinal column. This was cut open by its dorsal end, then lifted and 
detached from the embryo. A groove in the back of the embryo was created, from which 
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dorsal root ganglia could be dissociated, one by one. All ganglia were collected in a 6 
cm diameter Petri dish, containing 2 ml HBSS 1X. 
 
Ganglia from several rat embryos were pooled together and transferred to a 15 ml 
Falcon tube in HBSS 1X, centrifuged and the pellet was initially digested with 5 ml of 
20 Units/ml papain (Sigma, P4762) in papain activation solution (500 ml HBSS, 200 
mg L-Cysteine, 73 mg EDTA, 110 mg CaCl2 dihydrate, pH 7.4 with NaHCO3) for 30 
minutes at 37°C. After this initial digestion, cells were pelleted and subjected to a 
second digestion with a collagenase IV (Sigma, C5138)/dispase II (Roche, 165 859) 
cocktail for 40 minutes at 37°C and centrifuged again. Supernatant was discarded and 
the pellet was triturated with a fire-polished Pasteur pipette in 2 ml HBSS. A 5 ml 
solution of Percoll (Amersham Biosciences, 17089102) in L-15 medium (1 ml Percoll 
mixed with 4 ml L-15) was then carefully added to the bottom of the Falcon tube with 
an unpolished Pasteur pipette. Dissociated DRG neurons were centrifuged through this 
Percoll cushion for 8 minutes. The centrifuge brake was switched off to avoid 
vibrations. Cells were washed with 2 ml L-15 medium and the pellet was resuspended 
in a minimum volume of DRG culture medium, so that only 9 µl are finally plated per 
microfluidic chamber and/or MatTek dish. Typically, an embryo yielded 2000-5000 
DRG neurons. 
 
Cell culture platforms for DRG neurons (MatTek and microfluidic chambers) had to be 
coated before use with poly-D-lysine (Sigma, P1149) in sterile water at room 
temperature for a minimum of two hours, and then with a solution of 0.33 µg/ml 
laminin (Sigma, L-2020) in Neurobasal medium. The laminin coating was incubated at 
37°C, 7.5% CO2 for a minimum of two hours. As with spinal cord motor neurons, 
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immediately before plating cells, the laminin coating solution was removed and 
replaced with complete DRG medium in the case of MatTek dishes. Microfluidic 
chambers were left empty and medium was added after plating the cells. 
 
4.2.6 Superior Cervical Ganglia (SCG) neuron culture preparation. 
SCG cells were obtained from P0 rat pups. Animals were injected with a lethal dose of 
pentabarbital and subsequently decapitated leaving a long portion of the neck still 
attached to the head. Heads were then pinned down to a silicone rubber support surface 
to expose the neck. Excess tissue was removed with straight number 5 forceps until the 
carotid artery was exposed. The Superior Cervical Ganglion is attached to the carotid 
artery and therefore the entire region was removed so that tissue could be dissociated 
more comfortably in a separate Petri dish. 
 
Ganglia were collected in a Petri dish with 2 ml of HBSS 1X, and then transferred to a 
15 ml Falcon tube. Ganglia were pelleted with gentle centrifugation and resuspended in 
a collagenase IV (Sigma, C5138)/dispase II (Roche, 165 859) solution. They were then 
incubated in a water bath for 30 minutes at 37°C. Immediately after collagenase/ 
dispase digestion, cells were centrifuged again and the pellet digested with 0.025% 
trypsin (Sigma, T-1426) for 30 minutes at 37°C. Cells were pelleted again and triturated 
with a fire-polished Pasteur pipette repeatedly (15-20 times). After gentle 
centrifugation, cells were resuspended in a minimum amount of medium to load 9 µl 
cell suspension per microfluidic chamber. Approximately 1000-2000 cells per pup 
could be obtained. Poly-D-lysine/laminin coated microfluidic chambers were used for 
SCG sympathetic neurons, and the coating protocol was the same we used for DRG 
neurons (see above). 
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4.2.7 Chemoattraction protocol. 
When re-suspending a final pellet of DRG or SCG neurons for microfluidic cultures, a 
minimum volume was used so that only 9 µl would be loaded per chamber. 10 µl of 
medium (without cells) were loaded first in the axonal side, and then 9 µl of cell 
preparation were loaded in the somal side. After 60-90 mins incubation to let neurons 
adhere, the top left and top right wells were filled with 200 µl of 200 ng/ml NGF and 
cultures kept in an incubator at 37°C, 7.5% CO2. The following day (day 1) medium 
was changed to 160 µl (80 µl per well) of 20 ng/ml NGF in the somal side, and 200 µl 
(100 µl per well) of 200 ng/ml NGF in the axonal side. On day 3, medium was changed 
again. This time 160 µl of medium without NGF were added to the somal side, and 200 
µl of 200 ng/ml NGF were added to the axonal side. After this, every medium change 
was 200 µl of medium without NGF in the somal side, and 200 µl of 200 ng/ml NGF in 
the axonal side. Medium was changed every three days. 
 
4.2.8 Preparation of shRNA plasmids. 
3 µl of each primer (forward and reverse) were diluted in 44 µl of annealing buffer (100 
mM K-Acetate, 30 mM HEPES-KOH pH 7.4, 2 mM Mg-Acetate) and annealed in a 
PCR machine at 95°C for 4 minutes, then 70°C for 10 minutes. Reaction mix was 
cooled down at room temperature for at least an hour. 20 µg pLKO.1 vector was cut 
with Age1 and EcoR1 (New England Biolabs) in NE buffer 1 at 37°C for 6 hours. The 
enzymes were deactivated for 20 minutes at 65°C and the digestion mix was purified in 
a 2 % agarose gel, followed by extraction with QIAquick gel extraction kit (Qiagen). 3 
µl annealed oligos and 1 µl cut and purified pLKO.1 vector were ligated with T4 DNA 
ligase overnight at room temperature. Competent bacteria were electroporated with 
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ligation products and colonies were grown for DNA preparations (MAXI prep kit, 
Qiagen). Prepared plasmids were kept at -20°C until used. 
 
4.2.9 Preparation of mCherry plasmids by directed mutagenesis. 
Forward and reverse primers carrying the desired point mutation were designed based 
on the sequence for canine Rab7. These primers were used to amplify by PCR the 
mCherryRab7WT-carrying plasmid. PCR products were run in an agarose gel, cut and 
purified. They were kept at -20°C until used. 
 
4.2.10 Lentivirus packaging. 
HEK293T cells cultured in 10 cm Petri dishes were transfected with 7.5 µg VSV-G, 1 
µg PAX and 10 µg construct transfer plasmid using 29 µl Lipofectamine 2000 in 5 ml 
OptiMEM, following manufacturer’s instructions. Transfection medium in OptiMEM 
was incubated for 4 hours at 37°C, 7.5% CO2 and then replaced with 5 ml HEK293T 
complete medium (DMEM, 10 % fetal calf serum (FCS), 0.5 mM L-glutamine, 5 µg/ml 
penicillin/streptomycin). After 24 hours, this was replaced with 5 ml HEK293T 
complete medium and incubated further for 48 hours. The medium was then 
concentrated by ultracentrifugation at 25000rpm, 4°C, 2 hours. Virus concentration was 
then analysed using an ELISA kit (ClonTech, cat. No. 632200), which determines the 
concentration of the p24 structural protein of the virus. 
 
4.2.11 NanoJuice transfection. 
NanoJuice (Novagen) was used as indicated by the manufacturer. In short, 0.5 µl of 
NanoJuice Reagent and 0.5 µl of NanoJuice Booster were mixed in 50 µl of serum-free 
medium for each MatTek dish and incubated at room temperature for 5 minutes. Then 
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0.5 µg of DNA were added to this mix and incubated at room temperature for 15 
minutes. This 50 µl reaction mix was added dropwise to MatTek cultures containing 1 
ml of complete motor neuron or DRG medium. Cultures were incubated with the mix 
for 3 hours at 37°C, and 7.5 % CO2. Then medium was replace with fresh complete 
medium. 
 
An optimisation protocol was set up to determine the best ratio of reagents for 
transfection in motor neurons, as seen in Table 4.2. The optimal ratio was 0.5 µl 
NanoJuice Reagent, 0.5 µl NanoJuice Booster and 0.5 µg DNA. 
 
Table 4.2 Optimisation protocol for NanoJuice transfections. 
NJ Reagent 
(µl) 
NJ Booster 
(µl) 
DNA 
(µg) 
Comment 
1 0.5 0.5 1 neuron, 4 glial cells transfected 
0.5 0.5 0.5 Many neurons, almost no glia 
1 1 0.5 Many neurons, low expression in glia 
0.5 1 0.5 Cells under stress, low expression levels 
1 2 0.5 Toxic 
0.5 2 0.5 Toxic 
 
4.2.12 Labelling of p75NTR antibody. 
α-p75NTR (clone 5410) is dialysed against PBS for 48 hours at 4°C. 100 µl antibody are 
mixed with 10 µl NaHCO3 1 M and AlexaFluor488 carboxylic acid, tetrafluorophenyl 
(TFP) ester. Coupling reaction is incubated at room temperature for 1 hour. The reaction 
mix is then transferred to a dialysis cassette and dialysed against PBS at 4°C for 24 
Chapter 4. Materials and methods
 
 
Page 171 
hours, changing the PBS three times. AlexaFluor488-conjugated p75NTR was stored 
protected from light at 4°C and used at a 1:200 dilution. 
 
4.2.13 TeNT Hc transport experiments. 
Microfluidic cultures of spinal cord motor neurons or DRG sensory neurons were used 
for transport experiments. Axonal networks only were exposed to 40 nM TeNT Hc 
coupled to AlexaFluor488 or AlexaFluor555. In order to achieve fluidic isolation of the 
axonal compartment, 200 µl of unlabelled medium (either complete or Neurobasal 
medium) were added to the somal side (2 x 100 µl per well), whereas 160 µl of medium 
labelled with the toxin were added to the axonal side (2 x 80 µl per well). 
 
Cultures were typically incubated for about an hour at 37°C, 7.5% CO2. Immediately 
before imaging, cells were washed three times with imaging buffer (previously warmed 
to 37°C), and samples were then imaged in imaging medium (DMEM buffered with 30 
mM HEPES-NaOH, pH 7.4) in an inverted confocal microscope (Zeiss LSM 510 
equipped with a 63X, 1.4 NA Plan Apochromat oil-immersion objective). Typically 200 
frames were acquired at 1-2 frames/second. 
 
Kymographs were prepared using MetaMorph (Molecular Devices). For most 
kymographs the lsm file (a proprietory file format from Zeiss) was used directly. 
However, MetaMorph fails to open original lsm files if three different colours or more 
have been saved. When working with this type of files, it is necessary to save them as 
multi-TIFF, and then open the multi-TIFF files from MetaMorph using the following 
commands: Open special > Build stack > Numbered names > Select first and last. 
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Once a transport movie had been opened on MetaMorph, a region of interest (ROI) was 
selected, highlighting the axon. The ROIs from each frame of the movie were then 
stacked secuentially. The resulting image was a graphical representation of the entire 
transport movie, in which the x-axis corresponds to the time length of the movie, and 
the y-axis corresponds to the distant length of the axon. 
 
4.2.14 Co-transport experiments. 
For co-transport experiments visualising both TeNT Hc and CTB, 40 nM 
AlexaFluor488 TeNT Hc and 1 µg/ml AlexaFluor555 CTB were added together to the 
axonal networks of motor neurons and DRG sensory neurons. They were incubated for 
at least an hour at 37°C, 7.5% CO2. As for TeNT Hc alone, chambers were first washed 
with imaging medium and then warm imaging medium (DMEM buffered with 30 mM 
HEPES-NaOH, pH 7.4) was added immediately before imaging. 
 
4.2.15 Preparation of tetanus toxin. 
For this preparation, a TeNT Hc triple tag (HA/VSV-G/Cys) construct was used (Lalli 
et al., 2003). This construct has an N-terminal GST bound by a linker (LVPRGS, 
carrying a cleavage site for thrombin) to the HA tag (YPYDVPDYA). This is followed 
by a second linker (GSTG), the VSV-G tag (YTDIEMNRLGK), a third linker (GGS), 
the Cys tag (AEAAAREACCRECCAREAAAR), a final linker (ANSLD) and the TeNT 
Hc protein. 
 
Bacteria were electroporated with this construct and seeded in an ampicillin-containing 
agarose media. One colony was selected and grown overnight into 200 ml LB medium 
(plus 100 µg/ml ampicillin). The following day, this culture was inoculated in 2 litres of 
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2YT medium and grown at 37°C until an optical density of 0.8-1.1 was reached. 800 µl 
IPTG 1 M were then added to induce the expression of the GST fusion protein and the 
culture was grown at 30°C for 4 hours. Bacteria were collected by centrifugation at 
3000 rpm for 10 minutes. Pellets were resuspended in ice-cold PBS and centrifuged 
again at 3000 rpm for 15 minutes. These pellets were resuspended in ice-cold PBS and 
transferred to a 50 ml Falcon tube, pelleted again and snap frozen. 
 
They were kept at -80 °C overnight, then defrosted and resuspended in PBS with 0.05% 
Tween 20 (PBS-T). Resuspended pellet was then frozen in liquid nitrogen and thawed 
quickly in a room temperature water bath. Two more freeze-thaw cycles were 
performed before sonicating in three pulses of 15 seconds each. Sample was then 
ultracentrifuged for 20 minutes at 4°C and 28000 rpm (70 Ti rotor, Beckmann). The 
supernatant was added to 4 ml of 50 % immobilised GSH resin suspension, which had 
been equilibrated with PBS-T 0.05 % overnight. This was incubated at 4°C for 2 hours 
and then transferred to a packing column. Resin was then washed with 25 ml PBS and 
washed again three times with 5 ml of DNA-K elution buffer (10 mM MgSO4, 50 mM 
Tris-HCl pH 7.4, 2 mM ATP). These washes with DNA-K elution buffer are performed 
at 37°C. Finally resin is washed with 5 ml PBS-T 0.05 % (plus 0.5 M NaCl) and 5 ml 
TCB (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1 % 2-mercaptoethanol). 
 
The GST-TeNT Hc fusion protein was cleaved with 100 µl thrombin (0.8 U/mg) in 2.5 
ml TCB. Incubation was performed at room temperature for 30 minutes. Cleavage was 
repeated once more for an extra 30 minutes using fresh trombin solution. After 
cleavage, resin was washed with 2 ml TCB plus 0.5 mM PMSF (phenylmethylsulfonyl 
fluoride, a serine protease inhibitor) and 2 ml TCB (plus 0.5 mM PMSF and 0.5 M 
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NaCl). All supernatants were pooled as the eluate fraction and dialysed overnight in 20 
mM Na HEPES NaOH, pH 7.4, 300 mM NaCl, 1 % glycerol, 25 µM DTT. After 
dialysis, protein aggregates were removed by centrifugation at 4900 rpm for 10 minutes 
at 4°C. Protein concentration was measured with Bradford (BioRad), aliquoted and 
snap-frozen in liquid nitrogen. Aliquots were kept at -80°C until use. 
 
4.2.16 Labelling TeNT Hc with AlexaFluor maleimide. 
750 µg TeNT Hc (triple tagged) were mixed with 85 µl buffer (50 mM HEPES NaOH, 
pH 7.4, 250 mM NaCl) and 29 µl of TCEP 10 mM (tris(2-carboxyethyl)phosphine 
hydrochloride, a reducing agent). Distilled water is added to a final volume of 375 µl. of 
0.5 mg AlexaFluor maleimide in DMSO (dimethyl sulfoxide) solution (25 µl) were then 
added in a dropwise fashion, while stirring. This reaction mix was incubated overnight 
at 4°C, under shaking. The following day, reaction was stopped with 80 µl of a stop 
solution (50 mM Tris pH 8.0, 25 mM reduced glutathione). The reaction mix was 
loaded in a dialysis cassette and dialysed against PBS for three days. PBS was replaced 
on a daily basis. After three days, the labelled TeNT Hc solution was transferred to an 
eppendorf tube and kept at 4°C. A competition experiment was carried immediately 
after to confirm labelling of the probe. 
 
4.2.17 Labelling TeNT Hc with gold nanoparticles. 
100 µg TeNT Hc were used for this conjugation protocol. TeNT Hc was diluted to a 
concentration of 1 mg/ml and 100 µl of this solution were added dropwise to 10 ml of a 
10 nm gold nanoparticles suspension, with the pH adjusted to an optimised value of 6.9. 
This corresponds to the pI of TeNT Hc. The solution was stirred for 30 minutes to allow 
for the formation of aggregates, and then the pH was raised to 9.0 with 0.2 M sodium 
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carbonate. BSA is then added from a 10 % stock to a final 1 % concentration, and the 
solution was stirred for 15 minutes. This solution was centrifuged at 4°C at 45000 g for 
30 minutes and the pellet was resuspended in 1 ml storage buffer (20 mM Tris base, 150 
mM NaCl, 1 % BSA, HCl to pH 8.2). This solution was subjected to a quick pulse to 
bring down aggregates, transferred to a new tube, and kept at 4°C until use. 
 
4.2.18 Transmission Electron Microscopy. 
TEM samples were fixed in 2-5% glutaraldehyde plus 4% paraformaldehyde (PFA) in 
Sorensens phosphate buffer. For TEM the samples were post-fixed in osmium tetroxide, 
stained with tannic acid, dehydrated step-wise up to 100% ethanol and processed 
through to EPON epoxy resin. Thin sections (approx 70-75 nm thick) were cut, picked 
up on 150 mesh copper grids and stained with lead citrate before viewing in a FEI 
Tecnai Spirit Biotwin. 
 
4.2.19 Scanning Electron Microscopy. 
Microfluidic chambers were observed under a JEOL 6700 Field Emission Scanning 
Electron Microscope to assess that the size of all features corresponded to our design. 
For this purpose, microfluidic PDMS devices were cut, mounted on a cylinder stub and 
attached with a piece of carbon tab. The exposed surface was covered with a film of 
platinum in a sputter coater. 
 
4.2.20 Immunofluorescence. 
Cells were fixed with 4% PFA for 15-20 minutes at room temperature, then washed 
three times with PBS. Membranes were permeabilised with 0.1% Triton X-100 for 5 
minutes at room temperature and blocked with IFBB (immunofluorescence blocking 
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buffer: 10% normal goat serum, 2% BSA, 0.25% fish skin gelatine, in PBS) for an hour 
at room temperature to avoid non-specific binding of antibodies. After blocking, 
primary antibodies were added in IFBB for one hour at room temperature, or overnight 
at 4°C if using phospho-specific antibodies (i.e. pCREB). Samples were washed in PBS 
at room temperature and secondary antibodies added in IFBB for one hour at room 
temperature. Samples were washed with PBS and mounted with mowiol. If samples 
were confined within microfluidic chambers, 40 µl mowiol were added to each side of 
the chamber and kept overnight at room temperature protected from light. 
 
4.2.21 Western blotting. 
Samples for western blotting were collected from microfluidic chambers directly in 15-
20 µL of Laemmli buffer (4 % sodium dodecyl sulfate, 20 % glycerol, 10 % 2-
mercaptoethanol, 0.004 % bromophenol blue, 0.125 M Tris-HCl, pH 6.8), added to 
either side. Samples were pooled where necessary to increase the amount of protein for 
the analysis. Immediately after collection, samples were boiled for 2 minutes at 100°C, 
then either kept at -20°C or loaded directly on an SDS-PAGE gel (4-12 % NuPAGE® 
Bis-Tris Mini Gels, Invitrogen). Samples were typically run at 200 V for approximately 
1 hour, and then transferred onto methanol-activated PVDF membranes at 300 mA 
constant at 4°C for 1 hour. Membranes were stained with Ponceau red, and the resulting 
protein bands scanned before washing the membrane in PBS-T (PBS with added 0.1 % 
Tween 20). Membranes were then blocked with 5 % skimmed milk in PBS-T to avoid 
non-specific binding of antibodies. This treatment was done at room temperature for an 
hour. Primary antibodies were then added in 5 % skimmed milk in PBS-T at the 
appropriate concentrations and incubated either for 1 hour at room temperature or 
overnight at 4°C if using phospho-specific antibodies. After this step, membranes were 
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washed three times for 15 minutes each time in PBS-T. Secondary antibodies were then 
added in 5% skimmed milk in PBS-T 1:1000 for 1 hour at room temperature. After 
secondary antibody treatment, membranes were washed again three times in PBS-T for 
15 minutes, and finally washed three times in PBS for 10 minutes. Immunoreactive 
bands were detected by enhanced chemoluminiscence (ECL, GE healthcare) following 
manufacturer instructions and using high performance chemoluminiscence film (GE 
healthcare). Relevant bands were quantified with ImageJ software (gel analyzer 
options). 
 
4.2.22 Tukey’s box-and-whisker plot. 
Tukey’s box-and-whisker plot is a format to visualise in graphic manner relevant 
statistical information (Figure 4.1). 
 
 
Figure 4.01 Tukey’s box-and-whisker plot. The box represents 50% of the sample 
values (contained within the first and third quartiles, Q1 and Q3), the horizontal line 
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within the box is the median (second quartile, Q2), and the error bars are 1.5 times the 
interquartile range (IQR = Q3-Q1) or the sample range whichever is shorter. Outliers 
are represented as individual dots outside the range of the error bars. 
 
4.2.23 Statistical analysis. 
 
pCREB signalling experiments were subjected to one-way ANOVA (analysis of 
variance) to compare the means of the various conditions. This test determines whether 
the increase in CREB phosphorylation upon neurotrophin treatment is significantly 
different from control conditions. Tukey post-tests were used to compare all pairs of 
columns. Results corresponding to relevant pairs are indicated graphically on the 
appropriate figure. All statistical analyses were performed using GraphPad Prism. 
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